C an ce r_ is _ a_ gro u p _of_ di se as e s_ inv ol vi n g_ ab no r mal _ ce l l _ gro w t h _ w it h _ t he _ p ot ent ial _ to _ in va de _ or _ sp re a d_ to _ ot he r_ pa r t s_ of_ t he _ b o d y ._ T he se _ co n tr as t_ w it h _ be n ig n_ tu m or s ,_ w h ic h _ do _ no t_ sp re a d. _ P o ss i bl e_sign s_ and_ s ymptom s_ of_ c an ce r_ in c l u de _ a_ l um p ,_ ab no r mal _ bl ee di n g ,_ pr ol onge d_ co u g h ,_ un ex pl a in e d_ we ig h t_ lo ss ,_ and_ a_ ch an ge _ in_ b o we l _ m ov em ent s. _ W h il e_ t he se _ s ymptom s_ m a y _ in di c at e_ c an ce r ,_ t he y _ c an_ al s o _ h a ve_ ot he r_ c a u se s. _ O ver _ 1 0 0_ typ e s_ of_ c an ce r s_ af f ect_ hu man s.
A b o ut _ 3 3 % _of_ de at h s_ f ro m _ c an ce r_ ar e_ c a u se d_ b y _ to b a c co _ and_ al co ho l _ co n su m pt ion ,_ o be s it y ,_ l a c k_ of_ f ru it _ and_ v eg et ab le s_ in_ di et _ and_ l a c k_ of_ ex er ci se ._ O t he r_ factor s_ in c l u de _ ce r t a in_ in f ec t ion s ,_ ex p o su re _ to _ ion i z in g_ ra di ation ,_ and_ en vi ro n me n t al_ p ol l ut an t s. _ In f ec t ion _ w it h _ specif ic _ viru se s ,_ bact er i a ,_ and_ pa ra s it e s_ c a u se s_ ap pr o x im at el y _ 1 6 – 1 8 % _of_ c an ce r s_ wor l d w i de ._ T he se _ in f ec t i o u s_ ag ent s_ in c l u de _ H el ic o bact er_ p yl or i ,_ he pa t it is _ B ,_ he pa t it is _ C ,_ H P V ,_ E p st ei n – B ar r_ viru s ,_ H um an_ T- lym p ho tr op ic _ virus_ 1 ,_ K ap o s i ' s_ s ar co m a - as s o ci at e d_ he r p e s virus_ and_ M erk el_ ce l l _ p ol y oma viru s. _ H um an_ im mu no de f ic ie n cy _ viru s_( H I V )_ do e s_ no t_ di re ct l y _ c a u se _ c an ce r ,_ b ut _ it _ c a u se s_ im mu ne _ de f ic ie n cy _ t h at _ c an_ in c re as e_ t he _ ris k_ of_ c an ce r_ f ro m _ ot he r_ in f ec t ion s ,_ som et im e s_ u p _ to _ se ver al_ t hou s and f ol d_ ( in_ t he _ c as e_ of_ K ap o s i ' s_ s ar co m a ). _ I m p or t an t l y ,_ va c ci n ation _ ag a in st _ t he _ he pa t it is _ B _ virus_ and_ t he _ hu man _ pa p il lo m a virus_ h a ve_ be en_ s ho w n_ to _ ne ar l y _ el im in at e_ t he _ ris k_ of_ c an ce r s_ c a u se d_ b y _ t he se _ viru se s_ in_ p er s on s_ su c ce ss f ul l y _ va c ci n at e d_ pr i or _ to _ in f ec t ion .
T he se _ en vi ro n me n t al _f act or s_ act ,_ at _ le as t_ pa r t l y ,_ b y _ ch ang in g_ t he _ ge ne s_ of_ a_ ce l l ._ T yp ic all y ,_ man y _ ge ne t ic _ ch an ge s_ ar e_ re qu ir e d_ be f or e_ c an ce r_ de v el op s. _ A p pr o x im at el y _ 5 – 1 0 % _of_ c an ce r s_ ar e_ du e_ to _ in he r it e d_ ge ne t ic _ de f ec t s. _ C an ce r_ c an_ be _ de te ct e d_ b y _ ce r t a in_ s ign s_ and_ s ymptom s_ or _ sc re en in g_ te st s. _ I t_ is _ t he n_ typ ic all y _f ur t he r_ inv e st ig at e d_ b y _ medic al_ im ag in g_ and_ co n f ir me d_ b y _ b i op s y .
T he _ ris k_ of_ de v el op in g_ ce r t a in_ c an ce r s_ c an_ be _ re du ce d_ b y _ no t_ s m o kin g ,_ m a in t a in in g_ a_ he al t h y _ we ig h t,_ l im it in g_ al co ho l _ in t ak e,_ e at in g_ pl ent y _of_ v eg et ab le s ,_ f ru it s ,_ and_ w ho le _ g ra in s ,_ va c ci n ation _ ag a in st _ ce r t a in_ in f ec t i o u s_ di se as e s ,_ l im it in g_ co n su m pt ion _of_ pr o ce ss e d_ me at _ and_ re d_ me at ,_ and_ l im it in g_ ex p o su re _ to _ di re ct _ su n lig h t._ E ar l y _ de te ct ion _ t h ro u g h _ sc re en in g_ is _ u se f ul _f or _ ce r vi c al_ and_ co lo re ct al_ c an ce r ._ T he _ be ne f it s_ of_ sc re en in g_ f or _ br e as t_ c an ce r_ ar e_ co n tr ov er s ial ._ C an ce r_ is _ o f te n_ tr e at e d_ w it h _ som e_ co m b in ation _of_ ra di ation _ t he ra p y ,_ su rg er y ,_ chem ot he ra p y _ and_ t ar ge te d_ t he ra p y ._ M or e_ p er s on al i z e d_ t he ra p ie s_ t h at _ h ar ne ss _ a_ pa t ie n t ' s_ im mu ne _ s y st em _ ar e_ em er g in g_ in_ t he _f ie l d_ of_ c an ce r_ im mu no t he ra p y ._ P all i at iv e_ car e_ is _ a_ medic al_ spec ial t y _ t h at _ de l iv ers_ a d va n ce d_ pa in_ and_ s ympt om_ man ag em ent ,_ w h ic h _ m a y _ be _ pa r t ic ul ar l y _ im p or t an t_ in_ t ho se _ w it h _ a d va n ce d_ di se as e . ._ T he _ ch an ce _of_ su r vi va l _ de p en ds _ on _ t he _ typ e_ of_ c an ce r_ and_ ex te n t_ of_ di se as e_ at _ t he _ st ar t_ of_ tr e at me n t._ In _ ch il d re n_ un de r_ 1 5 _ at _ di ag no s is,_ t he _f iv e - y e ar _ su r vi va l _ ra te _ in_ t he _ de v el op e d_ wor l d_ is _ on _ a ver ag e_ 8 0 % ._ F or _ c an ce r_ in_ t he _ U n it e d_ S t at e s ,_ t he _ a ver ag e_ f iv e - y e ar _ su r vi va l _ ra te _ is _ 6 6 % _f or _ all _ ag e s.
In _ 201 5 ,_ ab o ut _ 9 0 . 5 _ mi l l ion _ p e op le _ wor l d w i de _ h a d_ c an ce r ._ In _ 201 9 ,_ an n u al_ c an ce r_ c as e s_ g re w _ b y _ 2 3 . 6 _ mi l l ion _ p e op le ,_ and_ t he re _ we re _ 1 0_ mi l l ion _ de at h s_ wor l d w i de ,_ re pr e se n t in g_ ov er_ t he _ pr e vi o u s_ de c a de _ in c re as e s_ of_ 2 6 % _ and_ 2 1 % ,_ resp ec t iv el y .
T he _ m o st _ co m m on _ typ e s_ of_ c an ce r_ in_ mal e s_ ar e_ l un g_ c an ce r ,_ pr o st at e_ c an ce r ,_ co lo re ct al_ c an ce r ,_ and_ st oma ch_ c an ce r ._ In _f em al e s ,_ t he _ m o st _ co m m on _ typ e s_ ar e_ br e as t_ c an ce r ,_ co lo re ct al_ c an ce r ,_ l un g_ c an ce r ,_ and_ ce r vi c al_ c an ce r ._ I f_ s kin _ c an ce r_ ot he r_ t h an_ me l an om a_ we re _ in c l u de d_ in_ to t al_ ne w _ c an ce r_ c as e s_ e a ch_ y e ar ,_ it _ w o ul d_ a c co un t_ f or _ ar o un d_ 4 0 % _of_ c as e s. _ In _ ch il d re n ,_ a c ut e_ lym p ho bl as t ic _ leukem i a_ and_ br a in_ tu m or s_ ar e_ m o st _ co m m on ,_ ex ce pt _ in_ A f r ic a ,_ w he re _ no n - H o d g kin _ lym p ho m a_ o c cur s_ m or e_ o f te n ._ In _ 201 2 ,_ ab o ut _ 1 6 5 , 0 0 0_ ch il d re n_ un de r_ 1 5 _ y e ar s_ of_ ag e_ we re _ di ag no se d_ w it h _ c an ce r ._ T he _ ris k_ of_ c an ce r_ in c re as e s_ s ign if ic an t l y _ w it h _ ag e,_ and_ man y _ c an ce r s_ o c cur _ m or e_ co m m on l y _ in_ de v el op e d_ co un tr ie s. _ R at e s_ ar e_ in c re as in g_ as _ m or e_ p e op le _ l iv e_ to _ an_ ol d_ ag e_ and_ as _ l if e st yl e_ ch an ge s_ o c cur _ in_ t he _ de v el op in g_ wor l d. _ T he _ g lo b al_ to t al_ ec on om ic _ co st s_ of_ c an ce r_ we re _ e st im at e d_ at _ U S $ 1 . 1 6 _ tr ill ion _( e qu iv al ent_ to _ $ 1 . 6 7 _ tr ill ion _ in_ 20 2 4 )_ p er_ y e ar _ as _of_ 201 0 .

E t ym olog y _ and_ de f in it ion s
T he _ wor d_ co me s_ f ro m _ t he _ an ci ent_ G reek _ κ α ρ κ ί ν ο ς ,_ me an in g_ ' c ra b '_ and_ ' tu m or ' ._ G reek _ p h y s ic i an s_ H i p p o c ra te s_ and_ G al en,_ am on g_ ot he r s ,_ no te d_ t he _ s im il ar it y _of_ c ra b s_ to _ som e_ tu m or s_ w it h _ s w ol le n_ v ei n s. _ T he _ wor d_ w as _ in tr o du ce d_ in_ E n g l is h _ in_ t he _ m o de r n_ medic al_ se n se _ ar o un d_ 1 6 0 0 .
C an ce r s_ co m pr is e_ a_ l ar ge _f am il y _of_ di se as e s_ t h at _ inv ol ve_ ab no r mal _ ce l l _ gro w t h _ w it h _ t he _ p ot ent ial _ to _ in va de _ or _ sp re a d_ to _ ot he r_ pa r t s_ of_ t he _ b o d y ._ T he y _f orm _ a_ su b se t_ of_ neoplas m s. _ A _ neoplas m _ or _ tu m or _ is _ a_ gro u p _of_ ce l l s_ t h at _ h a ve_ un de rg on e_ un regul at e d_ gro w t h _ and_ w ill _ o f te n_ f orm _ a_ m as s_ or _ l um p ,_ b ut _ m a y _ be _ di str i b ut e d_ di ff u se l y .
Al l _ tu m or _ ce l l s_ s ho w _ t he _ s i x _ h all m ar k s_ of_ c an ce r ._ T he se _ ch ar act er is t ic s_ ar e_ re qu ir e d_ to _ pr o du ce _ a_ malign an t_ tu m or ._ T he y _ in c l u de :

C ell _ gro w t h _ and_ di vi s ion _ ab se n t_ t he _ pr oper _ s ign al s
C ont in u o u s_ gro w t h _ and_ di vi s ion _ e v en_ g iv en_ co n tr ar y _ s ign al s
A v o i d an ce _of_ pr og ra m me d_ ce l l _ de at h
L im it le ss _ n um be r_ of_ ce l l _ di vi s ion s
P ro m ot in g_ bl oo d_ v e ss el_ co nst ru ct ion
In va s ion _of_ t is su e_ and_ f orm ation _of_ met as t as e s
T he _ pr og re ss ion _f ro m _ no r mal _ ce l l s_ to _ ce l l s_ t h at _ c an _f orm _ a_ de te ct ab le _ m as s_ to _ c an ce r_ inv ol v e s_ mu l t i pl e_ st ep s_ k no w n_ as _ malign an t_ pr og re ss ion .

S ign s_ and_ s ymptom s
W he n_ c an ce r_ be g in s ,_ it _ pr o du ce s_ no _ s ymptom s. _ S ign s_ and_ s ymptom s_ ap p e ar _ as _ t he _ m as s_ gro w s_ or _ ul ce ra te s. _ T he _f in di n g s_ t h at _ re su l t_ de p end_ on _ c an ce r ' s_ typ e_ and_ lo c ation ._ F e w _ s ymptom s_ ar e_ specif ic ._ M an y _f re qu ent l y _ o c cur _ in_ in di vi du als_ w ho _ h a ve_ ot he r_ co n di t ion s. _ C an ce r_ c an_ be _ di ff ic ul t_ to _ di ag no se _ and_ c an_ be _ co n s i de re d_ a_ " g re at _ im it at or " .
P e op le _ m a y _ be co me _ an x i o u s_ or _ de pr e ss e d_ p o st - di ag no s is ._ T he _ ris k_ of_ su ic i de _ in_ p e op le _ w it h _ c an ce r_ is _ ap pr o x im at el y _ do u bl e .

L o c al_ s ymptom s
L o c al_ s ymptom s_ m a y _ o c cur _ du e_ to _ t he _ m as s_ of_ t he _ tu m or _ or _ it s_ ul ce ra t ion ._ F or _ ex am pl e,_ m as s_ eff ec t s_ f ro m _ l un g_ c an ce r_ c an_ bl o c k_ t he _ br on ch u s_ re su l t in g_ in_ co u g h _ or _ p ne um on i a ;_ e s op h ag e al_ c an ce r_ c an_ c a u se _ n ar ro w in g_ of_ t he _ e s op h ag u s ,_ mak in g_ it _ di ff ic ul t_ or _ pa in f ul _ to _ s w al lo w ;_ and_ co lo re ct al_ c an ce r_ m a y _ le a d_ to _ n ar ro w in g_ or _ bl o c k ag e s_ in_ t he _ b o we l ,_ af f ec t in g_ b o we l _ h ab it s. _ M as se s_ in_ br e as t s_ or _ te st ic le s_ m a y _ pr o du ce _ o b se r va bl e_ l um p s. _ U l ce ra t ion _ c an_ c a u se _ bl ee di n g_ t h at _ c an_ le a d_ to _ s ymptom s_ su ch_ as _ co u g h in g_ u p _ bl oo d_ ( l un g_ c an ce r ),_ an em i a_ or _ re ct al_ bl ee di n g_ ( co lo n_ c an ce r ),_ bl oo d_ in_ t he _ ur in e_ ( bl a d de r_ c an ce r ),_ or _ ab no r mal _ va g in al_ bl ee di n g_ ( en do me tr ial _ or _ ce r vi c al_ c an ce r ). _ Al t hou g h _ lo c al i z e d_ pa in_ m a y _ o c cur _ in_ a d va n ce d_ c an ce r ,_ t he _ in it ial _ tu m or _ is _ u su all y _ pa in le ss ._ S om e_ c an ce r s_ c an_ c a u se _ a_ bui l du p _of_ f l ui d_ w it h in_ t he _ ch e st _ or _ ab do me n .

S y st em ic _ s ymptom s
S y st em ic _ s ymptom s_ m a y _ o c cur _ du e_ to _ t he _ b o d y ' s_ resp on se _ to _ t he _ c an ce r ._ T h is _ m a y _ in c l u de _f at ig u e,_ un in te n t ion al_ we ig h t_ lo ss ,_ or _ s kin _ ch an ge s. _ S om e_ c an ce r s_ c an_ c a u se _ a_ s y st em ic _ in f l am mat or y _ st at e_ t h at _ le a ds _ to _ ong o in g_ mu sc le _ lo ss _ and_ we ak ne ss ,_ k no w n_ as _ c a ch ex i a .
S om e_ c an ce r s ,_ su ch_ as _ H o d g kin ' s_ di se as e,_ leukem i as ,_ and_ l iv er_ or _ k i d ne y _ c an ce r s ,_ c an_ c a u se _ a_ p er s is te n t_ f e ver .
S ho r t ne ss _of_ br e at h ,_ c al le d_ d y sp ne a ,_ is _ a_ co m m on _ s ympt om_ of_ c an ce r_ and_ it s_ tr e at me n t._ T he _ c a u se s_ of_ c an ce r - re l at e d_ d y sp ne a_ c an_ in c l u de _ tu m or s_ in_ or _ ar o un d_ t he _ l un g ,_ bl o c k e d_ a ir w a y s ,_ f l ui d_ in_ t he _ l un g s ,_ p ne um on i a ,_ or _ tr e at me n t_ re act ion s_ in c l u di n g_ an_ al le rg ic _ resp on se ._ T re at me n t_ f or _ d y sp ne a_ in_ pa t ie n t s_ w it h _ a d va n ce d_ c an ce r_ c an_ in c l u de _f an s ,_ b il e v el_ vent il ation ,_ a c u pr e ss ur e / re f le x olog y _ and_ mu l t ic om p on ent_ no n p h arm a co lo g ic al_ in te r vent ion s.
S om e_s y st em ic _ s ymptom s_ of_ c an ce r_ ar e_ c a u se d_ b y _ ho r m on e s_ or _ ot he r_ m ol ec ul e s_ pr o du ce d_ b y _ t he _ tu m or ,_ k no w n_ as _ pa ra neoplas t ic _ s y n d ro me s. _ C om m on _ pa ra neoplas t ic _ s y n d ro me s_ in c l u de _ h yp er c al ce mi a ,_ w h ic h _ c an_ c a u se _ al te re d_ me n t al_ st at e,_ co nst i pa t ion _ and_ de h y dra t ion ,_ or _ h yp on at re mi a ,_ w h ic h _ c an_ al s o _ c a u se _ al te re d_ me n t al_ st at u s ,_ v om it ing,_ he a d a ch e s ,_ or _ se i z ur e s.

M et as t as is
M et as t as is _ is _ t he _ sp re a d_ of_ c an ce r_ to _ ot he r_ lo c ation s_ in_ t he _ b o d y ._ T he _ di sp er se d_ tu m or s_ ar e_ c al le d_ met as t at ic _ tu m or s ,_ w h il e_ t he _ or ig in al_ is _ c al le d_ t he _ pr im ar y _ tu m or ._ Al m o st _ all _ c an ce r s_ c an_ met as t as i z e ._ M o st _ c an ce r_ de at h s_ ar e_ du e_ to _ c an ce r_ t h at _ h as _ met as t as i z e d.
M et as t as is _ is _ co m m on _ in_ t he _ l at e_ st ag e s_ of_ c an ce r_ and_ it _ c an_ o c cur _ via_ t he _ bl oo d_ or _ t he _ lym p h at ic _ s y st em _ or _ b ot h ._ T he _ typ ic al_ st ep s_ in_ met as t as is _ ar e :

L o c al_ in va s ion
In tra va s ation _ in to _ t he _ bl oo d_ or _ lym p h
C ir c ul ation _ t h ro u g h _ t he _ b o d y .
E x tra va s ation _ in to _ t he _ ne w _ t is su e
P rol if er ation
An g i og en e s is
D if f eren t_ typ e s_ of_ c an ce r s_ te n d_ to _ met as t as i ze_ to _ pa r t ic ul ar _ org an s. _ O ver all ,_ t he _ m o st _ co m m on _ pl a ce s_ f or _ met as t as e s_ to _ o c cur _ ar e_ t he _ l un g s ,_ l iv er ,_ br a in ,_ and_ t he _ b on e s.
W h il e_s om e_ c an ce r s_ c an_ be _ cur e d_ if _ de te ct e d_ e ar l y ,_ met as t at ic _ c an ce r_ is _ m or e_ di ff ic ul t_ to _ tr e at _ and_ co n tr ol ._ N e ver t he le ss ,_ som e_ re ce n t_ tr e at me n t s_ ar e_ de m on st ra t in g_ en co ur ag in g_ re su l t s.

C a u se s
T he _ m a j or it y _of_ c an ce r s ,_ som e_ 9 0 – 9 5 % _of_ c as e s ,_ ar e_ du e_ to _ ge ne t ic _ mut ation s_ f ro m _ en vi ro n me n t al_ and_ l if e st yl e_ factor s. _ T he _ re m a in in g_ 5 – 1 0 % _ ar e_ du e_ to _ in he r it e d_ ge ne t ic s. _ E n vi ro n me n t al_ re f ers_ to _ an y _ c a u se _ t h at _ is _ no t_ in he r it e d,_ su ch_ as _ l if e st yl e,_ ec on om ic ,_ and_ beh a vi or al _f act or s_ and_ no t_ me re l y _ p ol l ut ion ._ C om m on _ en vi ro n me n t al _f act or s_ t h at _ co n tr i b ut e_ to _ c an ce r_ de at h _ in c l u de _ to b a c co _ u se _( 2 5 – 3 0 % ),_ di et _ and_ o be s it y _( 3 0 – 3 5 % ),_ in f ec t ion s_( 1 5 – 20 % ),_ ra di ation _( b ot h _ ion i z in g_ and_ no n - ion i z ing,_ u p _ to _ 1 0 % ),_ l a c k_ of_ p h y s ic al_ act iv it y ,_ and_ p ol l ut ion ._ P s y ch olog ic al_ st re ss _ do e s_ no t_ ap p e ar _ to _ be _ a_ ris k_ factor _f or _ t he _ on se t_ of_ c an ce r ,_ t hou g h _ it _ m a y _ wor se n_ o ut co me s_ in_ t ho se _ w ho _ al re a d y _ h a ve_ c an ce r .
E n vi ro n me n t al_ or _ l if e st yl e_ factor s_ t h at _ c a u se d_ c an ce r_ to _ de v el op_ in_ an_ in di vi du al_ c an_ be _ i de n t if ie d_ b y _ an al y z in g_ mut ation al_ s ign at ur e s_ f ro m _ ge no mi c _ se qu en ci n g_ of_ tu m or _ DNA ._ F or _ ex am pl e,_ t h is _ c an_ re v e al_ if _ l un g_ c an ce r_ w as _ c a u se d_ b y _ to b a c co _ s m o k e,_ if _ s kin _ c an ce r_ w as _ c a u se d_ b y _ U V _ ra di ation ,_ or _ if _ se co n d ar y _ c an ce r s_ we re _ c a u se d_ b y _ pr e vi o u s_ chem ot he ra p y _ tr e at me n t .
C an ce r_ is _ ge ne ra l l y _ no t_ a_ tran s mi ss i bl e_ di se as e ._E x ce pt ion s_ in c l u de _ ra re _ tran s mi ss ion s_ t h at _ o c cur _ w it h _ pr eg n an ci e s_ and_ o c c as ion al_ org an_ do no r s. _ H o we ver ,_ tran s mi ss i bl e_ in f ec t i o u s_ di se as e s_ su ch_ as _ he pa t it is _ B ,_ E p st ei n – B ar r ,_ H P V _ and_ A I D S _ in f ec t ion s ,_ c an_ co n tr i b ut e_ to _ t he _ de v el op me n t_ of_ c an ce r .

C he mi c al s
E x p o su re _ to _ pa r t ic ul ar _ su b st an ce s_ h a ve_ be en_ l in k e d_ to _ specif ic _ typ e s_ of_ c an ce r ._ T he se _ su b st an ce s_ ar e_ c al le d_ car ci no ge n s.
T o b a c co _ s m o k e,_ f or _ ex am pl e,_ c a u se s_ 9 0 % _of_ l un g_ c an ce r ._ T o b a c co _ u se _ c an_ c a u se _ c an ce r_ t h ro u g ho ut _ t he _ b o d y _ in c l u di n g_ in_ t he _ m o ut h _ and_ t h ro at ,_ l ar y n x ,_ e s op h ag u s ,_ st oma ch ,_ bl a d de r ,_ k i d ne y ,_ ce r vi x ,_ co lo n / re ct um ,_ l iv er_ and_ pa n c re as ._ T o b a c co _ s m o k e_ co n t a in s_ ov er _f if t y _ k no w n_ car ci no ge n s ,_ in c l u di n g_ n it ro s am in e s_ and_ p ol y cy c l ic _ ar om at ic _ h y d ro car b on s.
T o b a c co _ is _ resp on s i bl e_ f or _ ab o ut _ on e_ in _f iv e_ c an ce r_ de at h s_ wor l d w i de _ and_ ab o ut _ on e_ in_ t h re e_ in_ t he _ de v el op e d_ wor l d.
L un g_ c an ce r_ de at h _ ra te s_ in_ t he _ U n it e d_ S t at e s_ h a ve_ mi r ro re d_ s m o kin g_ pa t te r n s ,_ w it h _ in c re as e s_ in_ s m o kin g_ f ol lo we d_ b y _ dra mat ic _ in c re as e s_ in_ l un g_ c an ce r_ de at h _ ra te s_ and ,_ m or e_ re ce n t l y ,_ de c re as e s_ in_ s m o kin g_ ra te s_ s in ce _ t he _ 1 9 5 0 s_ f ol lo we d_ b y _ de c re as e s_ in_ l un g_ c an ce r_ de at h _ ra te s_ in_ me n_ s in ce _ 1 9 9 0 .
Al co ho l _ in c re as e s_ t he _ ris k_ of_ c an ce r_ of_ t he _ br e as t_ ( in_ w om en) ,_ t h ro at ,_ l iv er ,_ oe s op h ag u s ,_ m o ut h ,_ l ar y n x ,_ and_ co lo n .
In _ W e st er n_ Europ e,_ 1 0 % _of_ c an ce r s_ in_ mal e s_ and_ 3 % _of_ c an ce r s_ in _f em al e s_ ar e_ at tr i b ut e d_ to _ al co ho l _ ex p o su re ,_ e spec ial l y _ l iv er_ and_ di ge st iv e_ tra ct _ c an ce r s. _ C an ce r_ f ro m _ wor k - re l at e d_ su b st an ce _ ex p o su re s_ m a y _ c a u se _ bet we en_ 2 _ and_ 20 % _of_ c as e s ,_ c a u s in g_ at _ le as t_ 20 0 , 0 0 0_ de at h s. _ C an ce r s_ su ch_ as _ l un g_ c an ce r_ and_ me s ot he l i om a_ c an_ co me _f ro m _ in h al in g_ to b a c co _ s m o k e_ or _ as best o s_ f i be r s ,_ or _ leukem i a_ f ro m _ ex p o su re _ to _ be n zen e .
E x p o su re _ to _ p erf l u or oo ct an o ic _ a ci d_ ( P F O A ),_ w h ic h _ is _ pr e do mi n an t l y _ u se d_ in_ t he _ pr o du ct ion _of_ T e f lo n ,_ is _ k no w n_ to _ c a u se _ t w o _ kin ds _of_ c an ce r .
C he m ot he ra p y _ d ru g s_ su ch_ as _ pl at in um - b as e d_ co m p o un ds _ ar e_ car ci no ge n s_ t h at _ in c re as e_ t he _ ris k_ of_ se co n d ar y _ c an ce r s.
A z at h i op r in e,_ an_ im mu no sup pr e ss iv e_ medic ation ,_ is _ a_ car ci no ge n_ t h at _ c an_ c a u se _ pr im ar y _ tu m or s_ to _ de v el op .

D ie t_ and_ ex er ci se
D iet ,_ p h y s ic al_ in act iv it y ,_ and_ o be s it y _ ar e_ re l at e d_ to _ u p _ to _ 3 0 – 3 5 % _of_ c an ce r_ de at h s. _ In _ t he _ U n it e d_ S t at e s ,_ ex ce ss _ b o d y _ we ig h t_ is _ as s o ci at e d_ w it h _ t he _ de v el op me n t_ of_ man y _ typ e s_ of_ c an ce r_ and_ is _ a_ factor _ in_ 1 4 – 20 % _of_ c an ce r_ de at h s. _ A _ U K _ st u d y _ in c l u di n g_ d at a_ on _ ov er_ 5 _ mi l l ion _ p e op le _ s ho we d_ h ig he r_ b o d y _ m as s_ in de x _ to _ be _ re l at e d_ to _ at _ le as t_ 1 0_ typ e s_ of_ c an ce r_ and_ resp on s i bl e_ f or _ ar o un d_ 1 2 , 0 0 0_ c as e s_ e a ch_ y e ar _ in_ t h at _ co un tr y ._ P h y s ic al_ in act iv it y _ is _ be l iev e d_ to _ co n tr i b ut e_ to _ c an ce r_ ris k ,_ no t_ on l y _ t h ro u g h _ it s_ eff ect_ on _ b o d y _ we ig h t_ b ut _ al s o _ t h ro u g h _ ne g at iv e_ eff ec t s_ on _ t he _ im mu ne _ s y st em _ and_ en do c r in e_s y st em ._ M or e_ t h an_ h al f_ of_ t he _ eff ect_ f ro m _ t he _ di et _ is _ du e_ to _ ov er n ut r it ion _( e at in g_ to o _ mu ch ),_ ra t he r_ t h an _f ro m _ e at in g_ to o _f e w _ v eg et ab le s_ or _ ot he r_ he al t h f ul _f oo ds .
S om e_ specif ic _f oo ds _ ar e_ l in k e d_ to _ specif ic _ c an ce r s. _ A _ h ig h - s al t_ di et _ is _ l in k e d_ to _ g as tr ic _ c an ce r ._ A f l at o x in_ B 1 ,_ a_ f re qu ent_ f oo d_ co n t am in an t,_ c a u se s_ l iv er_ c an ce r ._ B et el_ n ut _ ch e w in g_ c an_ c a u se _ or al_ c an ce r ._ N ation al_ di ff eren ce s_ in_ di et ar y _ pr act ic e s_ m a y _ pa r t l y _ ex pl a in_ di ff eren ce s_ in_ c an ce r_ in ci de n ce ._ F or _ ex am pl e,_ g as tr ic _ c an ce r_ is _ m or e_ co m m on _ in_ J ap an_ du e_ to _ it s_ h ig h - s al t_ di et _ w h il e_ co lo n_ c an ce r_ is _ m or e_ co m m on _ in_ t he _ U n it e d_ S t at e s. _ I m mi g ra n t_ c an ce r_ pr o f il e s_ mi r ro r_ t ho se _of_ t he ir _ ne w _ co un tr y ,_ o f te n_ w it h in_ on e_ ge ne ra t ion .

In f ec t ion
W or l d w i de ,_ ap pr o x im at el y _ 1 8 % _of_ c an ce r_ de at h s_ ar e_ re l at e d_ to _ in f ec t i o u s_ di se as e s. _ T h is _ pr op or t ion _ ra n ge s_ f ro m _ a_ h ig h _of_ 2 5 % _ in_ A f r ic a_ to _ le ss _ t h an_ 1 0 % _ in_ t he _ de v el op e d_ wor l d. _ V ir u se s_ ar e_ t he _ u su al_ in f ec t i o u s_ ag ent s_ t h at _ c a u se _ c an ce r_ b ut _ bact er i a_ and_ pa ra s it e s_ m a y _ al s o _ pl a y _ a_ ro le ._ O n co viru se s_( viru se s_ t h at _ c an_ c a u se _ hu man _ c an ce r )_ in c l u de :

H um an_ pa p il lo m a viru s_( ce r vi c al_ c an ce r ) ,
E p st ei n – B ar r_ viru s_( B - ce l l _ lym p ho pr ol if er at iv e_ di se as e_ and_ n as op h ar y n ge al_ car ci no m a ) ,
K ap o s i ' s_ s ar co m a_ he r p e s viru s_( K ap o s i ' s_ s ar co m a_ and_ pr im ar y _ eff u s ion _ lym p ho m as ) ,
H ep at it is _ B _ and_ he pa t it is _ C _ viru se s_( he pa to ce l l ul ar _ car ci no m a )
H um an_ T- ce l l _ leukem i a_ viru s - 1 _( T- ce l l _ leukem i as ).
M erk el_ ce l l _ p ol y oma viru s_( M erk el_ ce l l _ car ci no m a )
B act er ial _ in f ec t ion _ m a y _ al s o _ in c re as e_ t he _ ris k_ of_ c an ce r ,_ as _ se en_ in

H el ic o bact er_ p yl or i - in du ce d_ g as tr ic _ car ci no m a .
C ol i bact in ,_ a_ ge no to x in_ as s o ci at e d_ w it h _ E sc he r ic h i a_ co l i _ in f ec t ion _( co lo re ct al_ c an ce r )
P ar as it ic _ in f ec t ion s_ as s o ci at e d_ w it h _ c an ce r_ in c l u de :

S ch is to som a_ h a em at o b i um _( s qu am o u s_ ce l l _ car ci no m a_ of_ t he _ bl a d de r )
T he _ l iv er _f l uk e s ,_ O p is t ho r ch is _ vi ver r in i _ and_ C lo no r ch is _ s in ens is _( ch ol ang i o car ci no m a ).

R a di ation
R a di ation _ ex p o su re _ su ch_ as _ ul tra vi ol et _ ra di ation _ and_ ra di o act iv e_ mat er ial _ is _ a_ ris k_ factor _f or _ c an ce r ._ M an y _ no n - me l an om a_ s kin _ c an ce r s_ ar e_ du e_ to _ ul tra vi ol et _ ra di ation ,_ m o st l y _f ro m _ su n lig h t._ S o ur ce s_ of_ ion i z in g_ ra di ation _ in c l u de _ medic al_ im ag in g_ and_ ra do n_ g as .
I on i z in g_ ra di ation _ is _ no t_ a_ pa r t ic ul ar l y _ st ro n g_ mut ag en._ R e s i de n t ial _ ex p o su re _ to _ ra do n_ g as ,_ f or _ ex am pl e,_ h as _ s im il ar _ c an ce r_ ris k s_ as _ pa ss iv e_s m o kin g ._ R a di ation _ is _ a_ m or e_ p ot ent_ s o ur ce _of_ c an ce r_ w he n_ co m b in e d_ w it h _ ot he r_ c an ce r - c a u s in g_ ag ent s ,_ su ch_ as _ ra do n_ pl u s_ to b a c co _ s m o k e ._ R a di ation _ c an_ c a u se _ c an ce r_ in_ m o st _ pa r t s_ of_ t he _ b o d y ,_in_ all _ an im als_ and_ at _ an y _ ag e ._ C h il d re n_ ar e_ t w ic e_ as _ l i k el y _ to _ de v el op_ ra di ation - in du ce d_ leukem i a_ as _ a du l t s ;_ ra di ation _ ex p o su re _ be f or e_ b ir t h _ h as _ te n_ t im e s_ t he _ eff ec t .
M e di c al_ u se _of_ ion i z in g_ ra di ation _ is _ a_ s mal l _ b ut _ gro w in g_ s o ur ce _of_ ra di ation - in du ce d_ c an ce r s. _ I on i z in g_ ra di ation _ m a y _ be _ u se d_ to _ tr e at _ ot he r_ c an ce r s ,_ b ut _ t h is _ m a y ,_in_ som e_ c as e s ,_ in du ce _ a_ se co n d_ f orm _of_ c an ce r ._ I t_ is _ al s o _ u se d_ in_ som e_ kin ds _of_ medic al_ im ag ing .
P ro lo n ge d_ ex p o su re _ to _ ul tra vi ol et _ ra di ation _f ro m _ t he _ su n_ c an_ le a d_ to _ me l an om a_ and_ ot he r_ s kin _ malign an ci e s. _ C le ar _ e vi de n ce _ e st ab l is he s_ ul tra vi ol et _ ra di ation ,_ e spec ial l y _ t he _ no n - ion i z in g_ medi um _ w a ve_ U V B ,_ as _ t he _ c a u se _of_ m o st _ no n - me l an om a_ s kin _ c an ce r s ,_ w h ic h _ ar e_ t he _ m o st _ co m m on _f orm s_ of_ c an ce r_ in_ t he _ wor l d.
N on - ion i z in g_ ra di o _f re qu en cy _ ra di ation _f ro m _ m o b il e_ p ho ne s ,_ el ec tr ic _ p o we r_ tran s mi ss ion _ and_ ot he r_ s im il ar _ s o ur ce s_ h as _ be en_ de sc r i be d_ as _ a_ p o ss i bl e_ car ci no ge n_ b y _ t he _ W or l d_ H e al t h _ O rg an i z ation ' s_ In te r n ation al_ A ge n cy _f or _ R e se ar ch_ on _ C an ce r ._E vi de n ce ,_ ho we ver ,_ h as _ no t_ sup p or te d_ a_ co n ce r n ._ T h is _ in c l u de s_ t h at _ st u di e s_ h a ve_ no t_ f o un d_ a_ co n s is te n t_ l in k_ bet we en_ m o b il e_ p ho ne _ ra di ation _ and_ c an ce r_ ris k .

H er e di t y
T he _ va st _ m a j or it y _of_ c an ce r s_ ar e_ no n - he re di t ar y _( sp or a di c ). _ H er e di t ar y _ c an ce r s_ ar e_ pr im ar il y _ c a u se d_ b y _ an_ in he r it e d_ ge ne t ic _ de f ec t._ L e ss _ t h an_ 0 . 3 % _of_ t he _ p op ul ation _ ar e_ car r ie r s_ of_ a_ ge ne t ic _ mut ation _ t h at _ h as _ a_ l ar ge _ eff ect_ on _ c an ce r_ ris k_ and_ t he se _ c a u se _ le ss _ t h an_ 3 – 1 0 % _of_ c an ce r ._ S om e_ of_ t he se _ s y n d ro me s_ in c l u de :_ ce r t a in_ in he r it e d_ mut ation s_ in_ t he _ ge ne s_ BRCA 1 _ and_ BRCA2 _ w it h _ a_ m or e_ t h an_ 7 5 % _ ris k_ of_ br e as t_ c an ce r_ and_ ov ar i an_ c an ce r ,_ and_ he re di t ar y _ no n p ol yp o s is _ co lo re ct al_ c an ce r_ ( H N P C C _ or _ L y n ch_ s y n d ro me ),_ w h ic h _ is _ pr e se n t_ in_ ab o ut _ 3 % _of_ p e op le _ w it h _ co lo re ct al_ c an ce r ,_ am on g_ ot he r s.
S t at is t ic all y _f or _ c an ce r s_ c a u s in g_ m o st _ m or t al it y ,_ t he _ re l at iv e_ ris k_ of_ de v el op in g_ co lo re ct al_ c an ce r_ w he n_ a_ f ir st - de g re e_ re l at iv e_ ( pa re n t,_ s i bl in g_ or _ ch il d )_ h as _ be en_ di ag no se d_ w it h _ it _ is _ ab o ut _ 2 ._ T he _ co r resp on di n g_ re l at iv e_ ris k_ is _ 1 . 5 _f or _ l un g_ c an ce r ,_ and_ 1 . 9 _f or _ pr o st at e_ c an ce r ._ F or _ br e as t_ c an ce r ,_ t he _ re l at iv e_ ris k_ is _ 1 . 8 _ w it h _ a_ f ir st - de g re e_ re l at iv e_ h a vi n g_ de v el op e d_ it _ at _ 5 0_ y e ar s_ of_ ag e_ or _ ol de r ,_ and_ 3 . 3 _ w he n_ t he _ re l at iv e_ de v el op e d_ it _ w he n_ be in g_ y o un ge r_ t h an_ 5 0_ y e ar s_ of_ ag e .
T al le r_ p e op le _ h a ve_ an_ in c re as e d_ ris k_ of_ c an ce r_ be c a u se _ t he y _ h a ve_ m or e_ ce l l s_ t h an_ s ho r te r_ p e op le ._ S in ce _ he ig h t_ is _ ge ne t ic all y _ de te r mi ne d_ to _ a_ l ar ge _ ex te n t,_ t al le r_ p e op le _ h a ve_ a_ he r it ab le _ in c re as e_ in_ c an ce r_ ris k .

P h y s ic al_ ag ent s
S om e_ su b st an ce s_ c a u se _ c an ce r_ pr im ar il y _ t h ro u g h _ t he ir _ p h y s ic al ,_ ra t he r_ t h an_ chemical ,_ eff ec t s. _ A _ pr om in ent_ ex am pl e_ of_ t h is _ is _ pr ol onge d_ ex p o su re _ to _ as best o s ,_ n at ur all y _ o c cur r in g_ mi ne ra l _f i be r s_ t h at _ ar e_ a_ m a j or _ c a u se _of_ me s ot he l i om a_ ( c an ce r_ of_ t he _ se ro u s_ me m br an e )_ u su all y _ t he _ se ro u s_ me m br an e_ su r ro un di n g_ t he _ l un g s. _ O t he r_ su b st an ce s_ in_ t h is _ c at eg or y ,_ in c l u di n g_ b ot h _ n at ur all y _ o c cur r in g_ and_ s y n t he t ic _ as best o s - l i k e_ f i be r s ,_ su ch_ as _ w ol l as to n it e,_ at t ap ul g it e,_ g l as s_ w oo l _ and_ ro c k_ w oo l ,_ ar e_ be l iev e d_ to _ h a ve_ s im il ar _ eff ec t s. _ N on - f i br o u s_ pa r t ic ul at e_ mat er ial s_ t h at _ c a u se _ c an ce r_ in c l u de _ p o w de re d_ met all ic _ co b al t_ and_ n ic k el_ and_ c r y st all in e_s il ic a_ ( qu ar t z ,_ c ris to b al it e_ and_ tr i d ym it e ). _ U su all y ,_ p h y s ic al_ car ci no ge n s_ mu st _ ge t_ in s i de _ t he _ b o d y _( su ch_ as _ t h ro u g h _ in h al ation )_ and_ re qu ir e_ y e ar s_ of_ ex p o su re _ to _ pr o du ce _ c an ce r .
P h y s ic al_ tra um a_ re su l t in g_ in_ c an ce r_ is _ re l at iv el y _ ra re ._ C l a im s_ t h at _ br e ak in g_ b on e s_ re su l te d_ in_ b on e_ c an ce r ,_ f or _ ex am pl e,_ h a ve_ no t_ be en_ pr oven ._ S im il ar l y ,_ p h y s ic al_ tra um a_ is _ no t_ a c ce pt e d_ as _ a_ c a u se _f or _ ce r vi c al_ c an ce r ,_ br e as t_ c an ce r_ or _ br a in_ c an ce r ._ O ne _ a c ce pt e d_ s o ur ce _ is _f re qu ent ,_ lo n g - te r m _ ap pl ic ation _of_ ho t_ o b j ec t s_ to _ t he _ b o d y ._ I t_ is _ p o ss i bl e_ t h at _ re p e at e d_ b ur n s_ on _ t he _ s am e_ pa r t_ of_ t he _ b o d y ,_ su ch_ as _ t ho se _ pr o du ce d_ b y _ kan ge r_ and_ k a ir o _ he at ers_ ( ch ar co al_ h and_ w ar me r s ),_ m a y _ pr o du ce _ s kin _ c an ce r ,_ e spec ial l y _ if _ car ci no ge n ic _ chemic als_ ar e_ al s o _ pr e se n t._ F re qu ent_ co n su m pt ion _of_ sc al di n g_ ho t_ te a_ m a y _ pr o du ce _ e s op h ag e al_ c an ce r ._ Gen er all y ,_ it _ is _ be l iev e d_ t h at _ c an ce r_ ar is e s ,_ or _ a_ pr e - ex is t in g_ c an ce r_ is _ en co ur ag e d,_ du r in g_ t he _ pr o ce ss _of_ he al ing,_ ra t he r_ t h an_ di re ct l y _ b y _ t he _ tra um a ._ H o we ver ,_ re p e at e d_ in j ur ie s_ to _ t he _ s am e_ t is su e s_ mi g h t_ pr om ot e_ ex ce ss iv e_ ce l l _ pr ol if er ation ,_ w h ic h _ co ul d_ t he n_ in c re as e_ t he _ o d ds _of_ a_ c an ce ro u s_ mut ation .
C h ro n ic _ in f l am mat ion _ h as _ be en_ h yp ot he s i z e d_ to _ di re ct l y _ c a u se _ mut ation ._ In f l am mat ion _ c an_ co n tr i b ut e_ to _ pr ol if er ation ,_ su r vi va l ,_ ang i og en e s is _ and_ mi g ra t ion _of_ c an ce r_ ce l l s_ b y _ in f l u en ci n g_ t he _ tu m or _ mi c ro en vi ro n me n t._ O n co ge ne s_ bui l d_ u p _ an_ in f l am mat or y _ pr o - tu m or ig en ic _ mi c ro en vi ro n me n t .

H orm on e s
H orm on e s_ al s o _ pl a y _ a_ ro le _ in_ t he _ de v el op me n t_ of_ c an ce r_ b y _ pr om ot in g_ ce l l _ pr ol if er ation ._ In su l in - l i k e_ gro w t h _f act or s_ and_ t he ir _ b in di n g_ pr ot ei n s_ pl a y _ a_ k e y _ ro le _ in_ c an ce r_ ce l l _ pr ol if er ation ,_ di ff eren t i ation _ and_ ap opto s is,_ su g ge st in g_ p o ss i bl e_ inv ol v em ent_ in_ car ci no ge ne s is .
H orm on e s_ ar e_ im p or t an t_ ag ent s_ in_ se x - re l at e d_ c an ce r s ,_ su ch_ as _ c an ce r_ of_ t he _ br e as t,_ en do me tr i um ,_ pr o st at e,_ ov ar y _ and_ te st is _ and_ al s o _of_ t h y ro i d_ c an ce r_ and_ b on e_ c an ce r ._ F or _ ex am pl e,_ t he _ d a u g h te r s_ of_ w om en_ w ho _ h a ve_ br e as t_ c an ce r_ h a ve_ s ign if ic an t l y _ h ig he r_ lev el s_ of_ e st ro ge n_ and_ pr og e st er on e_ t h an_ t he _ d a u g h te r s_ of_ w om en_ w it ho ut _ br e as t_ c an ce r ._ T he se _ h ig he r_ ho r m on e_ lev el s_ m a y _ ex pl a in_ t he ir _ h ig he r_ ris k_ of_ br e as t_ c an ce r ,_ e v en_in_ t he _ ab se n ce _of_ a_ br e as t - c an ce r_ ge ne ._ S im il ar l y ,_ me n_ of_ A f r ic an_ an ce str y _ h a ve_ s ign if ic an t l y _ h ig he r_ lev el s_ of_ te sto st er on e_ t h an_ me n_ of_ European_ an ce str y _ and_ h a ve_ a_ co r resp on di n g l y _ h ig he r_ lev el_ of_ pr o st at e_ c an ce r ._ M en_ of_ A s i an_ an ce str y ,_ w it h _ t he _ lo we st _ lev el s_ of_ te sto st er on e - act iv at in g_ and ro st an e di ol _ g l u cur on i de ,_ h a ve_ t he _ lo we st _ lev el s_ of_ pr o st at e_ c an ce r .
O t he r_ factor s_ ar e_ re le va n t :_ o be se _ p e op le _ h a ve_ h ig he r_ lev el s_ of_ som e_ ho r m on e s_ as s o ci at e d_ w it h _ c an ce r_ and_ a_ h ig he r_ ra te _of_ t ho se _ c an ce r s. _ W om en_ w ho _ t ak e_ ho r m on e_ re pl a ce me n t_ t he ra p y _ h a ve_ a_ h ig he r_ ris k_ of_ de v el op in g_ c an ce r s_ as s o ci at e d_ w it h _ t ho se _ ho r m on e s. _ O n_ t he _ ot he r_ h and ,_ p e op le _ w ho _ ex er ci se _f ar _ m or e_ t h an_ a ver ag e_ h a ve_ lo we r_ lev el s_ of_ t he se _ ho r m on e s_ and_ lo we r_ ris k_ of_ c an ce r ._ O st e o s ar co m a_ m a y _ be _ pr om ot e d_ b y _ gro w t h _ ho r m on e s. _ S om e_ tr e at me n t s_ and_ pr e vent ion _ ap pr o a ch e s_ lev er ag e_ t h is _ c a u se _ b y _ ar t if ic ial l y _ re du ci n g_ ho r m on e_ lev el s_ and_ t hu s_ di sc o ur ag in g_ ho r m on e - se n s it iv e_ c an ce r s.

A ut o im mu ne _ di se as e s
T he re _ is _ an_ as s o ci ation _ bet we en_ ce l i a c _ di se as e_ and_ an_ in c re as e d_ ris k_ of_ all _ c an ce r s. _ P e op le _ w it h _ un tr e at e d_ ce l i a c _ di se as e_ h a ve_ a_ h ig he r_ ris k ,_ b ut _ t h is _ ris k_ de c re as e s_ w it h _ t im e_ af te r_ di ag no s is _ and_ str ic t_ tr e at me n t._ T h is _ m a y _ be _ du e_ to _ t he _ a do pt ion _of_ a_ g l ut en - f re e_ di et ,_ w h ic h _ se em s_ to _ h a ve_ a_ pr ot ec t iv e_ ro le _ ag a in st _ t he _ de v el op me n t_ of_ malign an cy _ in_ p e op le _ w it h _ ce l i a c _ di se as e ._ H o we ver ,_ t he _ de l a y _ in_ di ag no s is _ and_ in it i ation _of_ a_ g l ut en - f re e_ di et _ se em s_ to _ in c re as e_ t he _ ris k_ of_ malign an ci e s. _ R at e s_ of_ g as tr o in te st in al_ c an ce r s_ ar e_ in c re as e d_ in_ p e op le _ w it h _ C ro h n ' s_ di se as e_ and_ ul ce ra t iv e_ co l it is,_ du e_ to _ ch ro n ic _ in f l am mat ion ._ I m mu no m o du l at or s_ and_ b i olog ic _ ag ent s_ u se d_ to _ tr e at _ t he se _ di se as e s_ m a y _ pr om ot e_ t he _ de v el op me n t_ of_ ex tra - in te st in al_ malign an ci e s.

P at ho p h y s i olog y
Gen et ic s
C an ce r_ is _f un d amen t all y _ a_ di se as e_ of_ t is su e_ gro w t h _ regul ation ._ F or _ a_ no r mal _ ce l l _ to _ tran s f orm _ in to _ a_ c an ce r_ ce l l ,_ t he _ ge ne s_ t h at _ regul at e_ ce l l _ gro w t h _ and_ di ff eren t i ation _ mu st _ be _ al te re d.
T he _ af f ec te d_ ge ne s_ ar e_ di vi de d_ in to _ t w o _ br o a d_ c at eg or ie s. _ O n co ge ne s_ ar e_ ge ne s_ t h at _ pr om ot e_ ce l l _ gro w t h _ and_ re pr o du ct ion ._ Tumor _ sup pr e ss or _ ge ne s_ ar e_ ge ne s_ t h at _ in h i b it _ ce l l _ di vi s ion _ and_ su r vi va l ._ M al ign an t_ tran s f orm ation _ c an_ o c cur _ t h ro u g h _ t he _f orm ation _of_ no v el_ onco ge ne s ,_ t he _ in ap pr op r i at e_ ov er - ex pr e ss ion _of_ no r mal _ onco ge ne s ,_ or _ b y _ t he _ un de r - ex pr e ss ion _ or _ di s ab l in g_ of_ tu m or _ sup pr e ss or _ ge ne s. _ T yp ic all y ,_ ch an ge s_ in_ mu l t i pl e_ ge ne s_ ar e_ re qu ir e d_ to _ tran s f orm _ a_ no r mal _ ce l l _ in to _ a_ c an ce r_ ce l l .
Gen et ic _ ch an ge s_ c an_ o c cur _ at _ di ff eren t_ lev el s_ and_ b y _ di ff eren t_ mechanis m s. _ T he _ g a in_ or _ lo ss _of_ an_ ent ir e_ ch ro m o som e_ c an_ o c cur _ t h ro u g h _ er ro r s_ in_ mi to s is ._ M or e_ co m m on _ ar e_ mut ation s ,_ w h ic h _ ar e_ ch an ge s_ in_ t he _ n u c le ot i de _ se qu en ce _of_ ge no mi c _ DNA .
L ar ge - sc ale_ mut ation s_ inv ol ve_ t he _ de le t ion _ or _ g a in_ of_ a_ p or t ion _of_ a_ ch ro m o som e ._ Gen om ic _ am pl if ic ation _ o c cur s_ w he n_ a_ ce l l _ g a in s_ co p ie s_( o f te n_ 20 _ or _ m or e )_ of_ a_ s mal l _ ch ro m o som al_ lo c u s ,_ u su all y _ co n t a in in g_ on e_ or _ m or e_ onco ge ne s_ and_ a d j a ce n t_ ge ne t ic _ mat er ial ._ T ra n sl o c ation _ o c cur s_ w he n_ t w o _ se pa ra te _ ch ro m o som al_ reg ion s_ be co me _ ab no r mal l y _f u se d,_ o f te n_ at _ a_ ch ar act er is t ic _ lo c ation ._ A _ we l l - k no w n_ ex am pl e_ of_ t h is _ is _ t he _ P h il a de l p h i a_ ch ro m o som e,_ or _ tran sl o c ation _of_ ch ro m o som e s_ 9 _ and_ 2 2 ,_ w h ic h _ o c cur s_ in_ ch ro n ic _ m y el og en o u s_ leukem i a_ and_ re su l t s_ in_ pr o du ct ion _of_ t he _ B C R - ab l _f u s ion _ pr ot ei n ,_ an_ onco ge n ic _ t y ro s in e_ kin as e .
S mal l - sc ale_ mut ation s_ in c l u de _ p o in t_ mut ation s ,_ de le t ion s ,_ and_ in se r t ion s ,_ w h ic h _ m a y _ o c cur _ in_ t he _ pr om ot er_ reg ion _of_ a_ ge ne _ and_ af f ect_ it s_ ex pr e ss ion ,_ or _ m a y _ o c cur _ in_ t he _ ge ne ' s_ co di n g_ se qu en ce _ and_ al te r_ t he _f unct ion _ or _ st ab il it y _of_ it s_ pr ot ei n_ pr o du ct ._D is ru pt ion _of_ a_ s ing le _ ge ne _ m a y _ al s o _ re su l t_ f ro m _ in te g ra t ion _of_ ge no mi c _ mat er ial _f ro m _ a_ DNA _ virus_ or _ re tr ov ir u s ,_ le a di n g_ to _ t he _ ex pr e ss ion _of_ vi ra l _ onco ge ne s_ in_ t he _ af f ec te d_ ce l l _ and_ it s_ de sc en d an t s.
R ep l ic ation _of_ t he _ d at a_ co n t a in e d_ w it h in_ t he _ DNA _of_ l iv in g_ ce l l s_ w ill _ pr o b ab il is t ic all y _ re su l t_ in_ som e_ er ro r s_( mut ation s ). _ C om pl ex _ er ro r_ co r re ct ion _ and_ pr e vent ion _ ar e_ bui l t_ in to _ t he _ pr o ce ss _ and_ s af eg u ar d_ t he _ ce l l _ ag a in st _ c an ce r ._ I f_ a_ s ign if ic an t_ er ro r_ o c cur s ,_ t he _ d am ag e d_ ce l l _ c an_ se l f - de st ru ct _ t h ro u g h _ pr og ra m me d_ ce l l _ de at h ,_ te r me d_ ap opto s is ._ I f_ t he _ er ro r_ co n tr ol _ pr o ce ss e s_ f a il ,_ t he n_ t he _ mut ation s_ w ill _ su r vi ve_ and_ be _ pa ss e d_ al on g_ to _ d a u g h te r_ ce l l s.
S om e_ en vi ro n me n t s_ mak e_ er ro r s_ m or e_ l i k el y _ to _ ar is e_ and_ pr op ag at e ._ S u ch_ en vi ro n me n t s_ c an_ in c l u de _ t he _ pr e se n ce _of_ di s ru pt iv e_ su b st an ce s_ c al le d_ car ci no ge n s ,_ re p e at e d_ p h y s ic al_ in j ur y ,_ he at ,_ ionis in g_ ra di ation ,_ or _ h yp o x i a .
T he _ er ro r s_ t h at _ c a u se _ c an ce r_ ar e_ se l f - am pl if y in g_ and_ co m p o un di n g ,_ f or _ ex am pl e :

A _ mut ation _ in_ t he _ er ro r - co r re ct in g_ m a ch in er y _of_ a_ ce l l _ mi g h t_ c a u se _ t h at _ ce l l _ and_ it s_ ch il d re n_ to _ a c c um ul at e_ er ro r s_ m or e_ ra p i d l y .
A _f ur t he r_ mut ation _ in_ an_ onco ge ne _ mi g h t_ c a u se _ t he _ ce l l _ to _ re pr o du ce _ m or e_ ra p i d l y _ and_ m or e_ f re qu ent l y _ t h an_ it s_ no r mal _ co un te r pa r t s.
A _f ur t he r_ mut ation _ m a y _ c a u se _ t he _ lo ss _of_ a_ tu m or _ sup pr e ss or _ ge ne ,_ di s ru pt in g_ t he _ ap opto s is _ s ign al in g_ pa t h w a y _ and_ im m or t al i z in g_ t he _ ce l l .
A _f ur t he r_ mut ation _ in_ t he _ s ign al in g_ m a ch in er y _of_ t he _ ce l l _ mi g h t_ se n d_ er ro r - c a u s in g_ s ign als_ to _ ne ar b y _ ce l l s.
T he _ tran s f orm ation _of_ a_ no r mal _ ce l l _ in to _ c an ce r_ is _ ak in_ to _ a_ ch a in_ re act ion _ c a u se d_ b y _ in it ial _ er ro r s ,_ w h ic h _ co m p o un d_ in to _ m or e_ se ver e_ er ro r s ,_ e a ch_ pr og re ss iv el y _ al lo w in g_ t he _ ce l l _ to _ e sc ap e_ m or e_ co n tr ol s_ t h at _ l im it _ no r mal _ t is su e_ gro w t h ._ T h is _ re be l l ion - l i k e_ sc en ar i o _ is _ an_ un de s ir ab le _ su r vi va l _of_ t he _f it te st ,_ w he re _ t he _ d r iv in g_ f or ce s_ of_ e vol ut ion _ wor k_ ag a in st _ t he _ b o d y ' s_ de s ig n_ and_ en f or ce me n t_ of_ or de r ._ O n ce _ c an ce r_ h as _ be g un _ to _ de v el op ,_ t h is _ ong o in g_ pr o ce ss ,_ te r me d_ c lo n al_ e vol ut ion ,_ d r iv e s_ pr og re ss ion _ to w ar ds _ m or e_ in va s iv e_ st ag e s. _ C lo n al_ e vol ut ion _ le a ds _ to _ in tra - tu m o ur _ he te ro ge ne it y _( c an ce r_ ce l l s_ w it h _ he te ro ge ne o u s_ mut ation s )_ t h at _ co m pl ic at e s_ de s ign in g_ eff ec t iv e_ tr e at me n t_ st ra te g ie s_ and_ re qu ir e s_ an_ e vol ut ion ar y _ ap pr o a ch_ to _ de s ign in g_ tr e at me n t .
C h ar act er is t ic _ ab il it ie s_ de v el op e d_ b y _ c an ce r s_ ar e_ di vi de d_ in to _ c at eg or ies ,_ specif ic all y _ e va s ion _of_ ap opto s is,_ se l f - su ff ic ie n cy _ in_ gro w t h _ s ign al s ,_ in se n s it iv it y _ to _ an t i - gro w t h _ s ign al s ,_ su st a in e d_ ang i og en e s is,_ l im it le ss _ re pl ic at iv e_ p ot ent ial ,_ met as t as is,_ re pr og ra m mi n g_ of_ en er g y _ met ab ol is m _ and_ e va s ion _of_ im mu ne _ de st ru ct ion .

E p ig en et ic s
T he _ c l as s ic al_ vi e w _of_ c an ce r_ is _ a_ se t_ of_ di se as e s_ d r iv en_ b y _ pr og re ss iv e_ ge ne t ic _ ab no r mal it ie s_ t h at _ in c l u de _ mut ation s_ in_ tu m or - sup pr e ss or _ ge ne s_ and_ onco ge ne s ,_ and_ in_ ch ro m o som al_ ab no r mal it ie s. _ A _ ro le _f or _ ep ig en et ic _ al te ra t ion s_ w as _ i de n t if ie d_ in_ t he _ e ar l y _ 2 1 st _ ce n tu r y .
E p ig en et ic _ al te ra t ion s_ ar e_ funct ion all y _ re le va n t_ m o di f ic ation s_ to _ t he _ ge no me _ t h at _ do _ no t_ ch an ge _ t he _ n u c le ot i de _ se qu en ce ._E x am pl e s_ of_ su ch_ m o di f ic ation s_ ar e_ ch an ge s_ in_ DNA _ met h yl ation _( h yp er met h yl ation _ and_ h yp om et h yl ation ),_ h is to ne _ m o di f ic ation _ and_ ch an ge s_ in_ ch ro m o som al_ ar ch it ec tu re _( c a u se d_ b y _ in ap pr op r i at e_ ex pr e ss ion _of_ pr ot ei n s_ su ch_ as _ H M G A 2 _ or _ H M G A 1 ). _ E a ch_ of_ t he se _ al te ra t ion s_ regul at e s_ ge ne _ ex pr e ss ion _ w it ho ut _ al te r in g_ t he _ un de r l y in g_ DNA _ se qu en ce ._ T he se _ ch an ge s_ m a y _ re m a in_ t h ro u g h _ ce l l _ di vi s ion s ,_ en du re _f or _ mu l t i pl e_ ge ne ra t ion s ,_ and_ c an_ be _ co n s i de re d_ as _ e qu iv al ent_ to _ mut ation s.
E p ig en et ic _ al te ra t ion s_ o c cur _f re qu ent l y _ in_ c an ce r s. _ A s_ an_ ex am pl e,_ on e_ st u d y _ l is te d_ pr ot ei n_ co di n g_ ge ne s_ t h at _ we re _f re qu ent l y _ al te re d_ in_ t he ir _ met h yl ation _ in_ as s o ci ation _ w it h _ co lo n_ c an ce r ._ T he se _ in c l u de d_ 1 4 7 _ h yp er met h yl at e d_ and_ 2 7 _ h yp om et h yl at e d_ ge ne s. _ O f_ t he _ h yp er met h yl at e d_ ge ne s ,_ 1 0_ we re _ h yp er met h yl at e d_ in_ 1 0 0 % _of_ co lo n_ c an ce r s_ and_ man y _ ot he r s_ we re _ h yp er met h yl at e d_ in_ m or e_ t h an_ 5 0 % _of_ co lo n_ c an ce r s.
W h il e_ ep ig en et ic _ al te ra t ion s_ ar e_ f o un d_ in_ c an ce r s ,_ t he _ ep ig en et ic _ al te ra t ion s_ in_ DNA _ re pa ir _ ge ne s ,_ c a u s in g_ re du ce d_ ex pr e ss ion _of_ DNA _ re pa ir _ pr ot ei n s ,_ m a y _ be _of_ pa r t ic ul ar _ im p or t an ce ._ S u ch_ al te ra t ion s_ m a y _ o c cur _ e ar l y _ in_ t he _ pr og re ss ion _ to _ c an ce r_ and_ ar e_ a_ p o ss i bl e_ c a u se _of_ t he _ ge ne t ic _ in st ab il it y _ ch ar act er is t ic _of_ c an ce r s.
R e du ce d_ ex pr e ss ion _of_ DNA _ re pa ir _ ge ne s_ di s ru pt s_ DNA _ re pa ir ._ T h is _ is _ s ho w n_ in_ t he _f ig ur e_ at _ t he _ 4 t h _ lev el _f ro m _ t he _ to p ._ ( In _ t he _f ig ur e,_ re d_ wor di n g_ in di c at e s_ t he _ ce n tr al_ ro le _of_ DNA _ d am ag e_ and_ de f ec t s_ in_ DNA _ re pa ir _ in_ t he _ pr og re ss ion _ to _ c an ce r . )_ W he n_ DNA _ re pa ir _ is _ de f ic ie n t_ DNA _ d am ag e_ re m a in s_ in_ ce l l s_ at _ a_ h ig he r_ t h an_ u su al_ lev el _( 5 t h _ lev el )_ and_ c a u se s_ in c re as e d_ f re qu en ci e s_ of_ mut ation _ and / or _ ep im ut ation _( 6 t h _ lev el ). _ Mut ation _ ra te s_ in c re as e_ su b st an t ial l y _ in_ ce l l s_ de f ec t iv e_ in_ DNA _ mi s mat ch_ re pa ir _ or _ in_ ho m olog o u s_ re co m b in ation al_ re pa ir _( H R R ). _ C h ro m o som al_ re ar ra n ge me n t s_ and_ an e u pl o i d y _ al s o _ in c re as e_ in_ H R R _ de f ec t iv e_ ce l l s.
H ig he r_ lev el s_ of_ DNA _ d am ag e_ c a u se _ in c re as e d_ mut ation _( r ig h t_ s i de _of_ f ig ur e )_ and_ in c re as e d_ ep im ut ation ._D ur in g_ re pa ir _of_ DNA _ do u bl e_ st ra n d_ br e ak s ,_ or _ re pa ir _of_ ot he r_ DNA _ d am ag e,_ in co m pl et el y _ c le ar e d_ re pa ir _ s it e s_ c an_ c a u se _ ep ig en et ic _ ge ne _ s il en ci n g .
D e f ic ie n t_ ex pr e ss ion _of_ DNA _ re pa ir _ pr ot ei n s_ du e_ to _ an_ in he r it e d_ mut ation _ c an_ in c re as e_ c an ce r_ ris k s. _ In di vi du als_ w it h _ an_ in he r it e d_ im pa ir me n t_ in_ an y _of_ 3 4 _ DNA _ re pa ir _ ge ne s_( se e_ ar t ic le _ DNA _ re pa ir - de f ic ie n cy _ di s or de r )_ h a ve_ in c re as e d_ c an ce r_ ris k ,_ w it h _ som e_ de f ec t s_ en su r in g_ a_ 1 0 0 % _ l if et im e_ ch an ce _of_ c an ce r_ ( e . g ._ p 5 3 _ mut ation s ). _ G er m l in e_ DNA _ re pa ir _ mut ation s_ ar e_ no te d_ on _ t he _f ig ur e ' s_ le f t_ s i de ._ H o we ver ,_ su ch_ ge r m l in e_ mut ation s_( w h ic h _ c a u se _ h ig h l y _ p en et ra n t_ c an ce r_ s y n d ro me s )_ ar e_ t he _ c a u se _of_ on l y _ ab o ut _ 1 _ p er ce n t_ of_ c an ce r s.
In _ sp or a di c _ c an ce r s ,_ de f ic ie n ci e s_ in_ DNA _ re pa ir _ ar e_ o c c as ion all y _ c a u se d_ b y _ a_ mut ation _ in_ a_ DNA _ re pa ir _ ge ne _ b ut _ ar e_ mu ch_ m or e_ f re qu ent l y _ c a u se d_ b y _ ep ig en et ic _ al te ra t ion s_ t h at _ re du ce _ or _ s il en ce _ ex pr e ss ion _of_ DNA _ re pa ir _ ge ne s. _ T h is _ is _ in di c at e d_ in_ t he _f ig ur e_ at _ t he _ 3 r d_ lev el ._ M an y _ st u di e s_ of_ he a v y _ met al - in du ce d_ car ci no ge ne s is _ s ho w _ t h at _ su ch_ he a v y _ met als_ c a u se _ a_ re du ct ion _ in_ ex pr e ss ion _of_ DNA _ re pa ir _ en z ym e s ,_ som e_ t h ro u g h _ ep ig en et ic _ mechanis m s. _ DNA _ re pa ir _ in h i b it ion _ is _ pr op o se d_ to _ be _ a_ pr e do mi n an t_ mechanis m _ in_ he a v y _ met al - in du ce d_ car ci no ge n ic it y ._ In _ a d di t ion ,_ f re qu ent_ ep ig en et ic _ al te ra t ion s_ of_ t he _ DNA _ se qu en ce s_ co de _f or _ s mal l _ R NA s_ c al le d_ mi c ro R NA s_( or _ mi R NA s ). _ mi R NA s_ do _ no t_ co de _f or _ pr ot ei n s ,_ b ut _ c an_ " t ar ge t "_ pr ot ei n - co di n g_ ge ne s_ and_ re du ce _ t he ir _ ex pr e ss ion .
C an ce r s_ u su all y _ ar is e_ f ro m _ an_ as se m bl ag e_ of_ mut ation s_ and_ ep im ut ation s_ t h at _ co n f er_ a_ se le ct iv e_ a d va n t ag e_ le a di n g_ to _ c lo n al_ ex pa n s ion _( se e_ F ie l d_ de f ec t s_ in_ pr og re ss ion _ to _ c an ce r ). _ Mut ation s ,_ ho we ver ,_ m a y _ no t_ be _ as _f re qu ent_ in_ c an ce r s_ as _ ep ig en et ic _ al te ra t ion s. _ An _ a ver ag e_ c an ce r_ of_ t he _ br e as t_ or _ co lo n_ c an_ h a ve_ ab o ut _ 6 0_ to _ 7 0_ pr ot ei n - al te r in g_ mut ation s ,_ of_ w h ic h _ ab o ut _ t h re e_ or _f o ur _ m a y _ be _ " d r iv er "_ mut ation s_ and_ t he _ re m a in in g_ on e s_ m a y _ be _ " pa ss en ge r "_ mut ation s.

M et as t as is
M et as t as is _ is _ t he _ sp re a d_ of_ c an ce r_ to _ ot he r_ lo c ation s_ in_ t he _ b o d y ._ T he _ di sp er se d_ tu m or s_ ar e_ c al le d_ met as t at ic _ tu m or s ,_ w h il e_ t he _ or ig in al_ is _ c al le d_ t he _ pr im ar y _ tu m or ._ Al m o st _ all _ c an ce r s_ c an_ met as t as i z e ._ M o st _ c an ce r_ de at h s_ ar e_ du e_ to _ c an ce r_ t h at _ h as _ met as t as i z e d.
M et as t as is _ is _ co m m on _ in_ t he _ l at e_ st ag e s_ of_ c an ce r_ and_ it _ c an_ o c cur _ via_ t he _ bl oo d_ or _ t he _ lym p h at ic _ s y st em _ or _ b ot h ._ T he _ typ ic al_ st ep s_ in_ met as t as is _ ar e_ lo c al_ in va s ion ,_ in tra va s ation _ in to _ t he _ bl oo d_ or _ lym p h ,_ ci r c ul ation _ t h ro u g h _ t he _ b o d y ,_ ex tra va s ation _ in to _ t he _ ne w _ t is su e,_ pr ol if er ation _ and_ ang i og en e s is ._D if f eren t_ typ e s_ of_ c an ce r s_ te n d_ to _ met as t as i ze_ to _ pa r t ic ul ar _ org an s ,_ b ut _ ov er all _ t he _ m o st _ co m m on _ pl a ce s_ f or _ met as t as e s_ to _ o c cur _ ar e_ t he _ l un g s ,_ l iv er ,_ br a in_ and_ t he _ b on e s.

M et ab ol is m
N orm al_ ce l l s_ typ ic all y _ ge ne ra te _ ab o ut _ 3 0 % _of_ en er g y _f ro m _ g l y co l y s is,_ w he re as _ m o st _ c an ce r s_ re l y _ on _ g l y co l y s is _f or _ en er g y _ pr o du ct ion _( W ar b ur g_ eff ec t ). _ B ut _ a_ mi no r it y _of_ c an ce r_ typ e s_ re l y _ on _ o x i d at iv e_ p ho sp ho r yl ation _ as _ t he _ pr im ar y _ en er g y _ s o ur ce ,_ in c l u di n g_ lym p ho m a ,_ leukem i a ,_ and_ en do me tr ial _ c an ce r ._E v en_in_ t he se _ c as e s ,_ ho we ver ,_ t he _ u se _of_ g l y co l y s is _ as _ an_ en er g y _ s o ur ce _ ra re l y _ ex ce e ds _ 6 0 % ._ A _f e w _ c an ce r s_ u se _ g l ut am in e_ as _ t he _ m a j or _ en er g y _ s o ur ce ,_ pa r t l y _ be c a u se _ it _ pr ov i de s_ n it ro ge n_ re qu ir e d_ f or _ n u c le ot i de _( DNA ,_ R NA )_ s y n t he s is ._ C an ce r_ st em _ ce l l s_ o f te n_ u se _ o x i d at iv e_ p ho sp ho r yl ation _ or _ g l ut am in e_ as _ a_ pr im ar y _ en er g y _ s o ur ce .

D i ag no s is
M o st _ c an ce r s_ ar e_ in it ial l y _ re co g n i z e d_ ei t he r_ be c a u se _of_ t he _ ap p e ar an ce _of_ s ign s_ or _ s ymptom s_ or _ t h ro u g h _ sc re en ing ._ N ei t he r_ of_ t he se _ le a ds _ to _ a_ de f in it iv e_ di ag no s is,_ w h ic h _ re qu ir e s_ t he _ ex am in ation _of_ a_ t is su e_s am pl e_ b y _ a_ pa t ho lo g is t._ P e op le _ w it h _ su spec te d_ c an ce r_ ar e_ inv e st ig at e d_ w it h _ medic al_ te st s. _ T he se _ co m m on l y _ in c l u de _ bl oo d_ te st s ,_ X - ra y s ,_ ( co n tr as t )_ C T _ scan s_ and_ en do sc op y .
T he _ t is su e_ di ag no s is _f ro m _ t he _ b i op s y _ in di c at e s_ t he _ typ e_ of_ ce l l _ t h at _ is _ pr ol if er at ing,_ it s_ h is to lo g ic al_ g ra de ,_ ge ne t ic _ ab no r mal it ie s_ and_ ot he r_ f e at ur e s. _ T og et he r ,_ t h is _ in f orm ation _ is _ u se f ul _ to _ e va l u at e_ t he _ pr og no s is _ and_ to _ ch oo se _ t he _ best _ tr e at me n t .
C y to ge ne t ic s_ and_ im mu no h is to chem is tr y _ ar e_ ot he r_ typ e s_ of_ t is su e_ te st s. _ T he se _ te st s_ pr ov i de _ in f orm ation _ ab o ut _ m ol ec ul ar _ ch an ge s_( su ch_ as _ mut ation s ,_ f u s ion _ ge ne s_ and_ n um er ic al_ ch ro m o som e_ ch an ge s )_ and_ m a y _ t hu s_ al s o _ in di c at e_ t he _ pr og no s is _ and_ best _ tr e at me n t .
C an ce r_ di ag no s is _ c an_ c a u se _ p s y ch olog ic al_ di st re ss _ and_ p s y ch o s o ci al_ in te r vent ion s ,_ su ch_ as _ t al kin g_ t he ra p y ,_ m a y _ he l p _ p e op le _ w it h _ t h is ._ S om e_ p e op le _ ch oo se _ to _ di sc lo se _ t he _ di ag no s is _ w i de l y ;_ ot he r s_ pr e f er_ to _ k ee p _ t he _ in f orm ation _ pr iv at e,_ e spec ial l y _ s ho r t l y _ af te r_ t he _ di ag no s is,_ or _ to _ di sc lo se _ it _ on l y _ pa r t ial l y _ or _ to _ se le ct e d_ p e op le .

C l as s if ic ation
C an ce r s_ ar e_ c l as s if ie d_ b y _ t he _ typ e_ of_ ce l l _ t h at _ t he _ tu m or _ ce l l s_ re se m bl e_ and_ is _ t he re f or e_ pr e su me d_ to _ be _ t he _ or ig in_ of_ t he _ tu m or ._ T he se _ typ e s_ in c l u de :

C ar ci no m a :_ C an ce r s_ de r iv e d_ f ro m _ ep it he l ial _ ce l l s. _ T h is _ gro u p _ in c l u de s_ man y _of_ t he _ m o st _ co m m on _ c an ce r s_ and_ in c l u de _ ne ar l y _ all _ t ho se _ in_ t he _ br e as t,_ pr o st at e,_ l un g ,_ pa n c re as _ and_ co lo n ._ M o st _of_ t he se _ ar e_ of_ t he _ a de no car ci no m a_ typ e,_ w h ic h _ me an s_ t h at _ t he _ c an ce r_ h as _ g l and - l i k e_ di ff eren t i ation .
S ar co m a :_ C an ce r s_ ar is in g_ f ro m _ co n ne ct iv e_ t is su e_ ( i . e ._ b on e,_ car t il ag e,_ f at ,_ ne r v e ),_ e a ch_ of_ w h ic h _ de v el op s_ f ro m _ ce l l s_ or ig in at in g_ in_ me se n ch ym al_ ce l l s_ o ut s i de _ t he _ b on e_ m ar ro w .
L ym p ho m a_ and_ leukem i a :_ T he se _ t w o _ c l as se s_ ar is e_ f ro m _ he mat op o iet ic _( bl oo d - f or mi n g )_ ce l l s_ t h at _ le a ve_ t he _ m ar ro w _ and_ te n d_ to _ mat ur e_ in_ t he _ lym p h _ no de s_ and_ bl oo d,_ resp ec t iv el y .
G er m _ ce l l _ tu m or :_ C an ce r s_ de r iv e d_ f ro m _ pl ur i p ot ent_ ce l l s ,_ m o st _ o f te n_ pr e se n t in g_ in_ t he _ te st ic le _ or _ t he _ ov ar y _( se mi no m a_ and_ d y s ge r mi no m a ,_ resp ec t iv el y ).
B l as to m a :_ C an ce r s_ de r iv e d_ f ro m _ im mat ur e_ " pr ec ur s or "_ ce l l s_ or _ em br y on ic _ t is su e .
C an ce r s_ ar e_ u su all y _ nam e d_ u s in g_ - car ci no m a ,_ - s ar co m a_ or _ - bl as to m a_ as _ a_ su ff i x ,_ w it h _ t he _ Lat in_ or _ G reek _ wor d_ f or _ t he _ org an_ or _ t is su e_ of_ or ig in_ as _ t he _ ro ot ._ F or _ ex am pl e,_ c an ce r s_ of_ t he _ l iv er_ pa re n ch ym a_ ar is in g_ f ro m _ malign an t_ ep it he l ial _ ce l l s_ is _ c al le d_ he pa to car ci no m a ,_ w h il e_ a_ malign an cy _ ar is in g_ f ro m _ pr im it iv e_ l iv er_ pr ec ur s or _ ce l l s_ is _ c al le d_ a_ he pa to bl as to m a_ and_ a_ c an ce r_ ar is in g_ f ro m _f at _ ce l l s_ is _ c al le d_ a_ l i p o s ar co m a ._ F or _ som e_ co m m on _ c an ce r s ,_ t he _ E n g l is h _ org an_ nam e_ is _ u se d. _ F or _ ex am pl e,_ t he _ m o st _ co m m on _ typ e_ of_ br e as t_ c an ce r_ is _ c al le d_ du ct al_ car ci no m a_ of_ t he _ br e as t._ H er e,_ t he _ a d j ec t iv e_ du ct al_ re f ers_ to _ t he _ ap p e ar an ce _of_ c an ce r_ un de r_ t he _ mi c ro sc op e,_ w h ic h _ su g ge st s_ t h at _ it _ h as _ or ig in at e d_ in_ t he _ mi l k_ du ct s.
B en ig n_ tu m or s_( w h ic h _ ar e_ no t_ c an ce r s )_ ar e_ nam e d_ u s in g_ - om a_ as _ a_ su ff i x _ w it h _ t he _ org an_ nam e_ as _ t he _ ro ot ._ F or _ ex am pl e,_ a_ be n ig n_ tu m or _of_ s m oo t h _ mu sc le _ ce l l s_ is _ c al le d_ a_ le i om y om a_ ( t he _ co m m on _ nam e_ of_ t h is _f re qu ent l y _ o c cur r in g_ be n ig n_ tu m or _ in_ t he _ ut er u s_ is _f i br o i d ). _ C on f u s ing l y ,_ som e_ typ e s_ of_ c an ce r_ u se _ t he _ - no m a_ su ff i x ,_ ex am pl e s_ in c l u di n g_ me l an om a_ and_ se mi no m a .
S om e_ typ e s_ of_ c an ce r_ ar e_ nam e d_ f or _ t he _ s i ze_ and_ s h ap e_ of_ t he _ ce l l s_ un de r_ a_ mi c ro sc op e,_ su ch_ as _ g i an t_ ce l l _ car ci no m a ,_ sp in d le _ ce l l _ car ci no m a_ and_ s mal l - ce l l _ car ci no m a .

Prevent ion
C an ce r_ pr e vent ion _ is _ de f in e d_ as _ act iv e_ me as ur e s_ to _ de c re as e_ c an ce r_ ris k ._ T he _ va st _ m a j or it y _of_ c an ce r_ c as e s_ ar e_ du e_ to _ en vi ro n me n t al_ ris k_ factor s. _ M an y _of_ t he se _ en vi ro n me n t al _f act or s_ ar e_ co n tr ol l ab le _ l if e st yl e_ ch o ic e s. _ T hu s ,_ c an ce r_ is _ ge ne ra l l y _ pr e vent ab le ._ B et we en_ 7 0 % _ and_ 9 0 % _of_ co m m on _ c an ce r s_ ar e_ du e_ to _ en vi ro n me n t al _f act or s_ and_ t he re f or e_ p ot ent ial l y _ pr e vent ab le .
G re at er_ t h an_ 3 0 % _of_ c an ce r_ de at h s_ co ul d_ be _ pr e v en te d_ b y _ a v o i di n g_ ris k_ factor s_ in c l u di n g :_ to b a c co ,_ ex ce ss _ we ig h t / o be s it y ,_ p oo r_ di et ,_ p h y s ic al_ in act iv it y ,_ al co ho l ,_ se x u all y _ tran s mi t te d_ in f ec t ion s_ and_ a ir _ p ol l ut ion ._ F ur t he r ,_ p ov er t y _ co ul d_ be _ co n s i de re d_ as _ an_ in di re ct _ ris k_ factor _ in_ hu man _ c an ce r s. _ N ot _ all _ en vi ro n me n t al_ c a u se s_ ar e_ co n tr ol l ab le ,_ su ch_ as _ n at ur all y _ o c cur r in g_ b a c k gro un d_ ra di ation _ and_ c an ce r s_ c a u se d_ t h ro u g h _ he re di t ar y _ ge ne t ic _ di s or de r s_ and_ t hu s_ ar e_ no t_ pr e vent ab le _ via_ p er s on al_ beh a vi or .
In _ 201 9 ,_ ~ 4 4 % _of_ all _ c an ce r_ de at h s_ – _ or _ ~ 4 . 5 _ M _ de at h s_ or _ ~ 1 0 5 _ mi l l ion _ lo st _ di s ab il it y - a d j u st e d_ l if e_ y e ar s_ – _ we re _ du e_ to _ k no w n_ c le ar l y _ pr e vent ab le _ ris k_ factor s ,_ le d_ b y _ s m o kin g ,_ al co ho l _ u se _ and_ h ig h _ B M I ,_ a c co r di n g_ to _ a_ G B D _ s y st em at ic _ an al y s is .

D iet ar y
W h il e_ man y _ di et ar y _ re co m me n d ation s_ h a ve_ be en_ pr op o se d_ to _ re du ce _ c an ce r_ ris k s ,_ t he _ e vi de n ce _ to _ sup p or t_ t he m _ is _ no t_ de f in it iv e ._ T he _ pr im ar y _ di et ar y _f act or s_ t h at _ in c re as e_ ris k_ ar e_ o be s it y _ and_ al co ho l _ co n su m pt ion ._D iet s_ lo w _ in _f ru it s_ and_ v eg et ab le s_ and_ h ig h _ in_ re d_ me at _ h a ve_ be en_ im pl ic at e d_ b ut _ re vi e w s_ and_ met a - an al y se s_ do _ no t_ co me _ to _ a_ co n s is te n t_ co n c l u s ion ._ A _ 201 4 _ met a - an al y s is _f o un d_ no _ re l ation s h i p _ bet we en _f ru it s_ and_ v eg et ab le s_ and_ c an ce r ._ C o ff ee _ is _ as s o ci at e d_ w it h _ a_ re du ce d_ ris k_ of_ l iv er_ c an ce r ._ S tu di e s_ h a ve_ l in k e d_ ex ce ss iv e_ co n su m pt ion _of_ re d_ or _ pr o ce ss e d_ me at _ to _ an_ in c re as e d_ ris k_ of_ br e as t_ c an ce r ,_ co lo n_ c an ce r_ and_ pa n c re at ic _ c an ce r ,_ a_ p he no me no n_ t h at _ co ul d_ be _ du e_ to _ t he _ pr e se n ce _of_ car ci no ge n s_ in_ me at s_ co o k e d_ at _ h ig h _ te m p er at ur e s. _ In _ 201 5 _ t he _ I A RC _ re p or te d_ t h at _ e at in g_ pr o ce ss e d_ me at _( e . g . ,_ b a co n ,_ h am ,_ ho t_ do g s ,_ s a u s ag e s )_ and ,_ to _ a_ le ss er_ de g ree ,_ re d_ me at _ w as _ l in k e d_ to _ som e_ c an ce r s.
D iet ar y _ re co m me n d ation s_ f or _ c an ce r_ pr e vent ion _ typ ic all y _ in c l u de _ an_ em p h as is _ on _ v eg et ab le s ,_ f ru it ,_ w ho le _ g ra in s_ and_ f is h _ and_ an_ a v o i d an ce _of_ pr o ce ss e d_ and_ re d_ me at _( be e f ,_ p or k ,_ l am b ),_ an im al _f at s ,_ p ic kl e d_ f oo ds _ and_ re f in e d_ car b o h y dra te s.

M e di c ation
M e di c ation s_ c an_ be _ u se d_ to _ pr e v ent_ c an ce r_ in_ a_ f e w _ ci r c um st an ce s. _ In _ t he _ ge ne ra l _ p op ul ation ,_ N S A I D s_ re du ce _ t he _ ris k_ of_ co lo re ct al_ c an ce r ;_ ho we ver ,_ du e_ to _ car di ov as c ul ar _ and_ g as tr o in te st in al_ s i de _ eff ec t s ,_ t he y _ c a u se _ ov er all _ h arm _ w he n_ u se d_ f or _ pr e vent ion ._ A sp ir in_ h as _ be en _f o un d_ to _ re du ce _ t he _ ris k_ of_ de at h _f ro m _ c an ce r_ b y _ ab o ut _ 7 % ._ C O X - 2 _ in h i b it or s_ m a y _ de c re as e_ t he _ ra te _of_ p ol yp _f orm ation _ in_ p e op le _ w it h _f am il ial _ a de no mat o u s_ p ol yp o s is ;_ ho we ver ,_ it _ is _ as s o ci at e d_ w it h _ t he _ s am e_ a d ver se _ eff ec t s_ as _ N S A I D s. _ D a il y _ u se _of_ t am o x if en_ or _ ra lo x if en e_ re du ce _ t he _ ris k_ of_ br e as t_ c an ce r_ in_ h ig h - ris k_ w om en._ T he _ be ne f it _ ver su s_ h arm _f or _ 5 - al p h a - re du ct as e_ in h i b it or _ su ch_ as _f in as te r i de _ is _ no t_ c le ar .
V it am in_ sup pl em ent ation _ do e s_ no t_ ap p e ar _ to _ be _ eff ec t iv e_ at _ pr e vent in g_ c an ce r ._ W h il e_ lo w _ bl oo d_ lev el s_ of_ vi t am in_ D _ ar e_ co r re l at e d_ w it h _ in c re as e d_ c an ce r_ ris k ,_ w he t he r_ t h is _ re l ation s h i p _ is _ c a u s al_ and_ vi t am in_ D _ sup pl em ent ation _ is _ pr ot ec t iv e_ is _ no t_ de te r mi ne d. _ O ne _ 201 4 _ re vi e w _f o un d_ t h at _ sup pl em ent s_ h a d_ no _ s ign if ic an t_ eff ect_ on _ c an ce r_ ris k ._ An ot he r_ 201 4 _ re vi e w _ co n c l u de d_ t h at _ vi t am in_ D 3 _ m a y _ de c re as e_ t he _ ris k_ of_ de at h _f ro m _ c an ce r_ ( on e_ f e we r_ de at h _ in_ 1 5 0_ p e op le _ tr e at e d_ ov er_ 5 _ y e ar s ),_ b ut _ co n ce r n s_ w it h _ t he _ qu al it y _of_ t he _ d at a_ we re _ no te d.
B et a - C ar ot en e_ sup pl em ent ation _ in c re as e s_ l un g_ c an ce r_ ra te s_ in_ t ho se _ w ho _ ar e_ h ig h _ ris k ._ F ol ic _ a ci d_ sup pl em ent ation _ is _ no t_ eff ec t iv e_ in_ pr e vent in g_ co lo n_ c an ce r_ and_ m a y _ in c re as e_ co lo n_ p ol yp s. _ S el en i um _ sup pl em ent ation _ h as _ no t_ be en_ s ho w n_ to _ re du ce _ t he _ ris k_ of_ c an ce r .

V a c ci n ation
V a c ci ne s_ h a ve_ be en_ de v el op e d_ t h at _ pr e v ent_ in f ec t ion _ b y _ som e_ car ci no ge n ic _ viru se s. _ H um an_ pa p il lo m a virus_ va c ci ne _( G ar d as il _ and_ C er va r i x )_ de c re as e_ t he _ ris k_ of_ de v el op in g_ ce r vi c al_ c an ce r ._ T he _ he pa t it is _ B _ va c ci ne _ pr e vent s_ in f ec t ion _ w it h _ he pa t it is _ B _ virus_ and_ t hu s_ de c re as e s_ t he _ ris k_ of_ l iv er_ c an ce r ._ T he _ a d mi n is tr ation _of_ hu man _ pa p il lo m a virus_ and_ he pa t it is _ B _ va c ci n ation s_ is _ re co m me n de d_ w he re _ re s o ur ce s_ al lo w .

S c re en ing
U n l i k e_ di ag no st ic _ eff or t s_ pr om pt e d_ b y _ s ymptom s_ and_ medic al_ s ign s ,_ c an ce r_ sc re en in g_ inv ol v e s_ eff or t s_ to _ de te ct _ c an ce r_ af te r_ it _ h as _f or med ,_ b ut _ be f or e_ an y _ no t ic e ab le _ s ymptom s_ ap p e ar ._ T h is _ m a y _ inv ol ve_ p h y s ic al_ ex am in ation ,_ bl oo d_ or _ ur in e_ te st s_ or _ medic al_ im ag ing .
C an ce r_ sc re en in g_ is _ no t_ a va il ab le _f or _ man y _ typ e s_ of_ c an ce r s. _ E v en_ w he n_ te st s_ ar e_ a va il ab le ,_ t he y _ m a y _ no t_ be _ re co m me n de d_ f or _ e ver y on e ._ U n iv er s al_ sc re en in g_ or _ m as s_ sc re en in g_ inv ol v e s_ sc re en in g_ e ver y on e ._ S el ec t iv e_ sc re en in g_ i de n t if ie s_ p e op le _ w ho _ ar e_ at _ h ig he r_ ris k ,_ su ch_ as _ p e op le _ w it h _ a_ f am il y _ h is to r y ._ S e ver al _f act or s_ ar e_ co n s i de re d_ to _ de te r mi ne _ w he t he r_ t he _ be ne f it s_ of_ sc re en in g_ o ut we ig h _ t he _ ris k s_ and_ t he _ co st s_ of_ sc re en ing ._ T he se _f act or s_ in c l u de :

P o ss i bl e_ h arm s_ f ro m _ t he _ sc re en in g_ te st :_ f or _ ex am pl e,_ X - ra y _ im ag e s_ inv ol ve_ ex p o su re _ to _ p ot ent ial l y _ h arm f ul _ ion i z in g_ ra di ation
T he _ l i k el i ho o d_ of_ t he _ te st _ co r re ct l y _ i de n t if y in g_ c an ce r
T he _ l i k el i ho o d_ t h at _ c an ce r_ is _ pr e se n t :_ S c re en in g_ is _ no t_ no r mal l y _ u se f ul _f or _ ra re _ c an ce r s.
P o ss i bl e_ h arm s_ f ro m _f ol lo w - u p _ pr o ce du re s
W he t he r_ a_ su it ab le _ tr e at me n t_ is _ a va il ab le
W he t he r_ e ar l y _ de te ct ion _ im pr ov e s_ tr e at me n t_ o ut co me s
W he t he r_ c an ce r_ w ill _ e ver _ ne e d_ tr e at me n t
W he t he r_ t he _ te st _ is _ a c ce pt ab le _ to _ t he _ p e op le :_ I f_ a_ sc re en in g_ te st _ is _ to o _ b ur de n som e_ ( f or _ ex am pl e,_ ex tr em el y _ pa in f ul ),_ t he n_ p e op le _ w ill _ re f u se _ to _ pa r t ic i pa te .
C o st

R ec om me n d ation s
U . S ._ Prevent iv e_ S er vi ce s_ T as k_ F or ce
T he _ U . S ._ Prevent iv e_ S er vi ce s_ T as k_ F or ce _( U S P S T F )_ is su e s_ re co m me n d ation s_ f or _ va r i o u s_ c an ce r s :

S tr ong l y _ re co m me n ds _ ce r vi c al_ c an ce r_ sc re en in g_ in_ w om en_ w ho _ ar e_ se x u all y _ act iv e_ and_ h a ve_ a_ ce r vi x _ at _ le as t_ un t il _ t he _ ag e_ of_ 6 5 .
R ec om me n d_ t h at _ A me r ic an s_ be _ sc re en e d_ f or _ co lo re ct al_ c an ce r_ via_ f ec al_ o c c ul t_ bl oo d_ te st ing,_ s ig m o i do sc op y ,_ or _ co lo no sc op y _ st ar t in g_ at _ ag e_ 5 0_ un t il _ ag e_ 7 5 .
E vi de n ce _ is _ in su ff ic ie n t_ to _ re co m me n d_ f or _ or _ ag a in st _ sc re en in g_ f or _ s kin _ c an ce r ,_ or al_ c an ce r ,_ l un g_ c an ce r ,_ or _ pr o st at e_ c an ce r_ in_ me n_ un de r_ 7 5 .
R o ut in e_ sc re en in g_ is _ no t_ re co m me n de d_ f or _ bl a d de r_ c an ce r ,_ te st ic ul ar _ c an ce r ,_ ov ar i an_ c an ce r ,_ pa n c re at ic _ c an ce r ,_ or _ pr o st at e_ c an ce r .
R ec om me n ds _ m am mog ra p h y _f or _ br e as t_ c an ce r_ sc re en in g_ e ver y _ t w o _ y e ar s_ f ro m _ ag e s_ 5 0 – 7 4 ,_ b ut _ do e s_ no t_ re co m me n d_ ei t he r_ br e as t_ se l f - ex am in ation _ or _ c l in ic al_ br e as t_ ex am in ation ._ A _ 201 3 _ C o ch ra ne _ re vi e w _ co n c l u de d_ t h at _ br e as t_ c an ce r_ sc re en in g_ b y _ m am mog ra p h y _ h a d_ no _ eff ect_ in_ re du ci n g_ m or t al it y _ be c a u se _of_ ov er di ag no s is _ and_ ov er tr e at me n t .

J ap an
S c re en s_ f or _ g as tr ic _ c an ce r_ u s in g_ p ho to f l u or og ra p h y _ du e_ to _ t he _ h ig h _ in ci de n ce _ t he re .

Gen et ic _ te st ing
Gen et ic _ te st in g_ f or _ in di vi du als_ at _ h ig h _ ris k_ of_ ce r t a in_ c an ce r s_ is _ re co m me n de d_ b y _ un o ff ic ial _ gro u p s. _ C ar r ie r s_ of_ t he se _ mut ation s_ m a y _ t he n_ un de rg o _ en h an ce d_ su r v ei l l an ce ,_ chem op re vent ion ,_ or _ pr e vent at iv e_ su rg er y _ to _ re du ce _ t he ir _ su b se qu ent_ ris k .

M an ag em ent
M an y _ tr e at me n t_ op t ion s_ f or _ c an ce r_ ex is t._ T he _ pr im ar y _ on e s_ in c l u de _ su rg er y ,_ chem ot he ra p y ,_ ra di ation _ t he ra p y ,_ ho r m on al_ t he ra p y ,_ t ar ge te d_ t he ra p y _ and_ pa l l i at iv e_ car e ._ W h ic h _ tr e at me n t s_ ar e_ u se d_ de p en ds _ on _ t he _ typ e,_ lo c ation _ and_ g ra de _of_ t he _ c an ce r_ as _ we l l _ as _ t he _ pa t ie n t ' s_ he al t h _ and_ pr e f eren ce s. _ T he _ tr e at me n t_ in te n t_ m a y _ or _ m a y _ no t_ be _ cur at iv e .

C he m ot he ra p y
C he m ot he ra p y _ is _ t he _ tr e at me n t_ of_ c an ce r_ w it h _ on e_ or _ m or e_ cy to to x ic _ an t i - neoplas t ic _ d ru g s_( chem ot he ra p e ut ic _ ag ent s )_ as _ pa r t_ of_ a_ st and ar di z e d_ reg im en._ T he _ te r m _ en co m pa ss e s_ a_ va r iet y _of_ d ru g s ,_ w h ic h _ ar e_ di vi de d_ in to _ br o a d_ c at eg or ie s_ su ch_ as _ al k yl at in g_ ag ent s_ and_ an t im et ab ol it e s. _ T ra di t ion al_ chem ot he ra p e ut ic _ ag ent s_ act _ b y _ k ill in g_ ce l l s_ t h at _ di vi de _ ra p i d l y ,_ a_ c r it ic al_ pr oper t y _of_ m o st _ c an ce r_ ce l l s.
I t_ w as _f o un d_ t h at _ pr ov i di n g_ co m b in e d_ cy to to x ic _ d ru g s_ is _ bet te r_ t h an_ a_ s ing le _ d ru g ,_ a_ pr o ce ss _ c al le d_ t he _ co m b in ation _ t he ra p y ,_ w h ic h _ h as _ an_ a d va n t ag e_ in_ t he _ st at is t ic s_ of_ su r vi va l _ and_ resp on se _ to _ t he _ tu m or _ and_ in_ t he _ pr og re ss _of_ t he _ di se as e ._ A _ C o ch ra ne _ re vi e w _ co n c l u de d_ t h at _ co m b in e d_ t he ra p y _ w as _ m or e_ eff ec t iv e_ in_ tr e at in g_ met as t as i z e d_ br e as t_ c an ce r ._ H o we ver ,_ ge ne ra l l y _ it _ is _ no t_ ce r t a in_ w he t he r_ co m b in ation _ chem ot he ra p y _ le a ds _ to _ bet te r_ he al t h _ o ut co me s ,_ w he n_ b ot h _ su r vi va l _ and_ to x ic it y _ ar e_ co n s i de re d.
T ar ge te d_ t he ra p y _ is _ a_ f orm _of_ chem ot he ra p y _ t h at _ t ar ge t s_ specif ic _ m ol ec ul ar _ di ff eren ce s_ bet we en_ c an ce r_ and_ no r mal _ ce l l s. _ T he _f ir st _ t ar ge te d_ t he ra p ie s_ bl o c k e d_ t he _ e st ro ge n_ re ce pt or _ m ol ec ul e,_ in h i b it in g_ t he _ gro w t h _of_ br e as t_ c an ce r ._ An ot he r_ co m m on _ ex am pl e_ is _ t he _ c l as s_ of_ B c r - A bl _ in h i b it or s ,_ w h ic h _ ar e_ u se d_ to _ tr e at _ ch ro n ic _ m y el og en o u s_ leukem i a_ ( C M L ). _ C ur re n t l y ,_ t ar ge te d_ t he ra p ie s_ ex is t_ f or _ man y _of_ t he _ m o st _ co m m on _ c an ce r_ typ e s ,_ in c l u di n g_ bl a d de r_ c an ce r ,_ br e as t_ c an ce r ,_ co lo re ct al_ c an ce r ,_ k i d ne y _ c an ce r ,_ leukem i a ,_ l iv er_ c an ce r ,_ l un g_ c an ce r ,_ lym p ho m a ,_ pa n c re at ic _ c an ce r ,_ pr o st at e_ c an ce r ,_ s kin _ c an ce r ,_ and_ t h y ro i d_ c an ce r_ as _ we l l _ as _ ot he r_ c an ce r_ typ e s.
T he _ eff ic a cy _of_ chem ot he ra p y _ de p en ds _ on _ t he _ typ e_ of_ c an ce r_ and_ t he _ st ag e ._ In _ co m b in ation _ w it h _ su rg er y ,_ chem ot he ra p y _ h as _ pr oven _ u se f ul _ in_ c an ce r_ typ e s_ in c l u di n g_ br e as t_ c an ce r ,_ co lo re ct al_ c an ce r ,_ pa n c re at ic _ c an ce r ,_ o st e og en ic _ s ar co m a ,_ te st ic ul ar _ c an ce r ,_ ov ar i an_ c an ce r_ and_ ce r t a in_ l un g_ c an ce r s. _ C he m ot he ra p y _ is _ cur at iv e_ f or _ som e_ c an ce r s ,_ su ch_ as _ som e_ leukem i as ,_ in eff ec t iv e_ in_ som e_ br a in_ tu m or s ,_ and_ ne e d le ss _ in_ ot he r s ,_ su ch_ as _ m o st _ no n - me l an om a_ s kin _ c an ce r s. _ T he _ eff ec t iv en e ss _of_ chem ot he ra p y _ is _ o f te n_ l im it e d_ b y _ it s_ to x ic it y _ to _ ot he r_ t is su e s_ in_ t he _ b o d y ._E v en_ w he n_ chem ot he ra p y _ do e s_ no t_ pr ov i de _ a_ p er man ent_ cur e,_ it _ m a y _ be _ u se f ul _ to _ re du ce _ s ymptom s_ su ch_ as _ pa in_ or _ to _ re du ce _ t he _ s i ze_ of_ an_ in oper ab le _ tu m or _ in_ t he _ ho p e_ t h at _ su rg er y _ w ill _ be co me _ p o ss i bl e_ in_ t he _f ut ur e .

R a di ation
R a di ation _ t he ra p y _ inv ol v e s_ t he _ u se _of_ ion i z in g_ ra di ation _ in_ an_ at te m pt _ to _ ei t he r_ cur e_ or _ im pr ov e_s ymptom s. _ I t_ wor k s_ b y _ d am ag in g_ t he _ DNA _of_ c an ce ro u s_ t is su e,_ c a u s in g_ mi to t ic _ c at as tr op he _ re su l t in g_ in_ t he _ de at h _of_ t he _ c an ce r_ ce l l s. _ T o _ sp ar e_ no r mal _ t is su e s_( su ch_ as _ s kin _ or _ org an s ,_ w h ic h _ ra di ation _ mu st _ pa ss _ t h ro u g h _ to _ tr e at _ t he _ tu m or ),_ s h ap e d_ ra di ation _ be am s_ ar e_ a im e d_ f ro m _ mu l t i pl e_ ex p o su re _ ang le s_ to _ in te r se ct _ at _ t he _ tu m or ,_ pr ov i di n g_ a_ mu ch_ l ar ge r_ do se _ t he re _ t h an_ in_ t he _ su r ro un di n g ,_ he al t h y _ t is su e ._ A s_ w it h _ chem ot he ra p y ,_ c an ce r s_ va r y _ in_ t he ir _ resp on se _ to _ ra di ation _ t he ra p y .
R a di ation _ t he ra p y _ is _ u se d_ in_ ab o ut _ h al f_ of_ c as e s. _ T he _ ra di ation _ c an_ be _ ei t he r_ f ro m _ in te r n al_ s o ur ce s_( br a ch y t he ra p y )_ or _ ex te r n al_ s o ur ce s. _ T he _ ra di ation _ is _ m o st _ co m m on l y _ lo w _ en er g y _ X - ra y s_ f or _ tr e at in g_ s kin _ c an ce r s ,_ w h il e_ h ig he r_ en er g y _ X - ra y s_ ar e_ u se d_ f or _ c an ce r s_ w it h in_ t he _ b o d y ._ R a di ation _ is _ typ ic all y _ u se d_ in_ a d di t ion _ to _ su rg er y _ and / or _ chem ot he ra p y ._ F or _ ce r t a in_ typ e s_ of_ c an ce r ,_ su ch_ as _ e ar l y _ he a d_ and_ ne c k_ c an ce r ,_ it _ m a y _ be _ u se d_ al on e ._ R a di ation _ t he ra p y _ af te r_ su rg er y _f or _ br a in_ met as t as e s_ h as _ be en_ s ho w n_ to _ no t_ im pr ov e_ ov er all _ su r vi va l _ in_ pa t ie n t s_ co m pa re d_ to _ su rg er y _ al on e ._ F or _ pa in f ul _ b on e_ met as t as is,_ ra di ation _ t he ra p y _ h as _ be en _f o un d_ to _ be _ eff ec t iv e_ in_ ab o ut _ 7 0 % _of_ pa t ie n t s.

S ur ge r y
S ur ge r y _ is _ t he _ pr im ar y _ met ho d_ of_ tr e at me n t_ f or _ m o st _ is ol at e d,_ s ol i d_ c an ce r s_ and_ m a y _ pl a y _ a_ ro le _ in_ pa l l i ation _ and_ pr ol ong ation _of_ su r vi va l ._ I t_ is _ typ ic all y _ an_ im p or t an t_ pa r t_ of_ t he _ de f in it iv e_ di ag no s is _ and_ st ag in g_ of_ tu m or s ,_ as _ b i op sie s_ ar e_ u su all y _ re qu ir e d. _ In _ lo c al i z e d_ c an ce r ,_ su rg er y _ typ ic all y _ at te m pt s_ to _ re m ov e_ t he _ ent ir e_ m as s_ al on g_ w it h ,_in_ ce r t a in_ c as e s ,_ t he _ lym p h _ no de s_ in_ t he _ ar e a ._ F or _ som e_ typ e s_ of_ c an ce r_ t h is _ is _ su ff ic ie n t_ to _ el im in at e_ t he _ c an ce r .

P all i at iv e_ car e
P all i at iv e_ car e_ is _ tr e at me n t_ t h at _ at te m pt s_ to _ he l p _ t he _ pa t ie n t_ f ee l _ bet te r_ and_ m a y _ be _ co m b in e d_ w it h _ an_ at te m pt _ to _ tr e at _ t he _ c an ce r ._ P all i at iv e_ car e_ in c l u de s_ act ion _ to _ re du ce _ p h y s ic al ,_ em ot ion al ,_ sp ir itu al_ and_ p s y ch o - s o ci al_ di st re ss ._ U n l i k e_ tr e at me n t_ t h at _ is _ a im e d_ at _ di re ct l y _ k ill in g_ c an ce r_ ce l l s ,_ t he _ pr im ar y _ g o al_ of_ pa l l i at iv e_ car e_ is _ to _ im pr ov e_ qu al it y _of_ l if e .
P e op le _ at _ all _ st ag e s_ of_ c an ce r_ tr e at me n t_ typ ic all y _ re ce iv e_s om e_ kin d_ of_ pa l l i at iv e_ car e ._ In _ som e_ c as e s ,_ medic al_ spec ial t y _ pr o f e ss ion al_ org an i z ation s_ re co m me n d_ t h at _ pa t ie n t s_ and_ p h y s ic i an s_ resp on d_ to _ c an ce r_ on l y _ w it h _ pa l l i at iv e_ car e ._ T h is _ ap pl ie s_ to _ pa t ie n t s_ w ho :

D is pl a y _ lo w _ p erf orm an ce _ st at u s ,_ im pl y in g_ l im it e d_ ab il it y _ to _ car e_ f or _ t he m se l v e s
R ec ei v e d_ no _ be ne f it _f ro m _ pr i or _ e vi de n ce - b as e d_ tr e at me n t s
A re _ no t_ el ig i bl e_ to _ pa r t ic i pa te _ in_ an y _ ap pr op r i at e_ c l in ic al_ tr ial
N o _ st ro n g_ e vi de n ce _ im pl ie s_ t h at _ tr e at me n t_ w o ul d_ be _ eff ec t iv e
P all i at iv e_ car e_ m a y _ be _ co n f u se d_ w it h _ ho sp ic e_ and_ t he re f or e_ on l y _ in di c at e d_ w he n_ p e op le _ ap pr o a ch_ end_ of_ l if e ._ L i k e_ ho sp ic e_ car e,_ pa l l i at iv e_ car e_ at te m pt s_ to _ he l p _ t he _ pa t ie n t_ co p e_ w it h _ t he ir _ im medi at e_ ne e ds _ and_ to _ in c re as e_ co m f or t._ U n l i k e_ ho sp ic e_ car e,_ pa l l i at iv e_ car e_ do e s_ no t_ re qu ir e_ p e op le _ to _ st op_ tr e at me n t_ a im e d_ at _ t he _ c an ce r .
M ul t i pl e_ n ation al_ medic al_ g ui de l in e s_ re co m me n d_ e ar l y _ pa l l i at iv e_ car e_ f or _ pa t ie n t s_ w ho se _ c an ce r_ h as _ pr o du ce d_ di st re ss in g_ s ymptom s_ or _ w ho _ ne e d_ he l p _ co p in g_ w it h _ t he ir _ ill ne ss ._ In _ pa t ie n t s_ f ir st _ di ag no se d_ w it h _ met as t at ic _ di se as e,_ pa l l i at iv e_ car e_ m a y _ be _ im medi at el y _ in di c at e d. _ P all i at iv e_ car e_ is _ in di c at e d_ f or _ pa t ie n t s_ w it h _ a_ pr og no s is _of_ le ss _ t h an_ 1 2 _ m ont h s_ of_ l if e_ e v en_ g iv en_ ag g re ss iv e_ tr e at me n t .

I m mu no t he ra p y
A _ va r iet y _of_ t he ra p ie s_ u s in g_ im mu no t he ra p y ,_ st im ul at in g_ or _ he l p in g_ t he _ im mu ne _ s y st em _ to _f ig h t_ c an ce r ,_ h a ve_ co me _ in to _ u se _ s in ce _ 1 9 9 7 ._ A p pr o a ch e s_ in c l u de :

M on o c lo n al_ an t i b o d y _ t he ra p y
C he c k p o in t_ t he ra p y _( t he ra p y _ t h at _ t ar ge t s_ t he _ im mu ne _ ch ec k p o in t s_ or _ regul at or s_ of_ t he _ im mu ne _ s y st em )
A do pt iv e_ ce l l _ tran s f er
C A R _ T _ ce l l

L as er_ t he ra p y
L as er_ t he ra p y _ u se s_ h ig h - in te n s it y _ lig h t_ to _ tr e at _ c an ce r_ b y _ s h r in kin g_ or _ de st ro y in g_ tu m or s_ or _ pr ec an ce ro u s_ gro w t h s. _ L as ers_ ar e_ m o st _ co m m on l y _ u se d_ to _ tr e at _ sup erf ic ial _ c an ce r s_ t h at _ ar e_ on _ t he _ su rf a ce _of_ t he _ b o d y _ or _ t he _ l in in g_ of_ in te r n al_ org an s. _ I t_ is _ u se d_ to _ tr e at _ b as al_ ce l l _ s kin _ c an ce r_ and_ t he _ ver y _ e ar l y _ st ag e s_ of_ ot he r s_ l i k e_ ce r vi c al ,_ p en il e,_ va g in al ,_ vul va r ,_ and_ no n - s mal l _ ce l l _ l un g_ c an ce r ._ I t_ is _ o f te n_ co m b in e d_ w it h _ ot he r_ tr e at me n t s ,_ su ch_ as _ su rg er y ,_ chem ot he ra p y ,_ or _ ra di ation _ t he ra p y ._ L as er - in du ce d_ in te r st it ial _ t he r m ot he ra p y _( L I T T ),_ or _ in te r st it ial _ l as er_ p ho to co ag ul ation ,_ u se s_ l as ers_ to _ tr e at _ som e_ c an ce r s_ u s in g_ h yp er t he r mi a ,_ w h ic h _ u se s_ he at _ to _ s h r in k_ tu m or s_ b y _ d am ag in g_ or _ k ill in g_ c an ce r_ ce l l s. _ L as er_ ar e_ m or e_ pr ec is e_ t h an_ su rg er y _ and_ c a u se _ le ss _ d am ag e,_ pa in ,_ bl ee di n g ,_ s we l l ing,_ and_ sc ar r ing ._ A _ di s a d va n t ag e_ is _ t h at _ su rg e on s_ mu st _ h a ve_ spec ial i z e d_ tra in ing ._ I t_ m a y _ be _ m or e_ ex p ens iv e_ t h an_ ot he r_ tr e at me n t s.

Al te r n at iv e_ medi ci ne
C om pl em ent ar y _ and_ al te r n at iv e_ c an ce r_ tr e at me n t s_ ar e_ a_ di ver se _ gro u p _of_ t he ra p ies ,_ pr act ic e s_ and_ pr o du ct s_ t h at _ ar e_ no t_ pa r t_ of_ co n vent ion al_ medi ci ne ._ " C om pl em ent ar y _ medi ci ne "_ re f ers_ to _ met ho ds _ and_ su b st an ce s_ u se d_ al on g_ w it h _ co n vent ion al_ medi ci ne ,_ w h il e_ " al te r n at iv e_ medi ci ne "_ re f ers_ to _ co m p o un ds _ u se d_ in st e a d_ of_ co n vent ion al_ medi ci ne ._ M o st _ co m pl em ent ar y _ and_ al te r n at iv e_ medi ci ne s_ f or _ c an ce r_ h a ve_ no t_ be en_ st u di e d_ or _ te st e d_ u s in g_ co n vent ion al_ te ch n i qu e s_ su ch_ as _ c l in ic al_ tr ial s. _ S om e_ al te r n at iv e_ tr e at me n t s_ h a ve_ be en_ inv e st ig at e d_ and_ s ho w n_ to _ be _ in eff ec t iv e_ b ut _ st ill _ co n t in u e_ to _ be _ m ar k et e d_ and_ pr om ot e d. _ C an ce r_ re se ar ch er_ An d re w _ J ._ V ic k ers_ st at e d,_ " T he _ l ab el_ ' un pr oven '_ is _ in ap pr op r i at e_ f or _ su ch_ t he ra p ies ;_ it _ is _ t im e_ to _ as se r t_ t h at _ man y _ al te r n at iv e_ c an ce r_ t he ra p ie s_ h a ve_ be en_ ' di sp ro v en ' . "

P ro g no s is
S ur vi va l _ ra te s_ va r y _ b y _ c an ce r_ typ e_ and_ b y _ t he _ st ag e_ at _ w h ic h _ it _ is _ di ag no se d,_ ra n g in g_ f ro m _ m a j or it y _ su r vi va l _ to _ co m pl et e_ m or t al it y _f iv e_ y e ar s_ af te r_ di ag no s is ._ O n ce _ a_ c an ce r_ h as _ met as t as i z e d,_ pr og no s is _ no r mal l y _ be co me s_ mu ch_ wor se ._ A b o ut _ h al f_ of_ pa t ie n t s_ re ce iv in g_ tr e at me n t_ f or _ in va s iv e_ c an ce r_ ( ex c l u di n g_ car ci no m a_ in_ s itu _ and_ no n - me l an om a_ s kin _ c an ce r s )_ di e_ f ro m _ t h at _ c an ce r_ or _ it s_ tr e at me n t._ A _ m a j or it y _of_ c an ce r_ de at h s_ ar e_ du e_ to _ met as t as e s_ of_ t he _ pr im ar y _ tu m or .
S ur vi va l _ is _ wor se _ in_ t he _ de v el op in g_ wor l d,_ pa r t l y _ be c a u se _ t he _ typ e s_ of_ c an ce r_ t h at _ ar e_ m o st _ co m m on _ t he re _ ar e_ h ar de r_ to _ tr e at _ t h an_ t ho se _ as s o ci at e d_ w it h _ de v el op e d_ co un tr ie s.
T ho se _ w ho _ su r vi ve_ c an ce r_ de v el op_ a_ se co n d_ pr im ar y _ c an ce r_ at _ ab o ut _ t w ic e_ t he _ ra te _of_ t ho se _ ne ver _ di ag no se d. _ T he _ in c re as e d_ ris k_ is _ be l iev e d_ to _ be _ du e_ to _ t he _ ra n do m _ ch an ce _of_ de v el op in g_ an y _ c an ce r ,_ t he _ l i k el i ho o d_ of_ su r vi vi n g_ t he _f ir st _ c an ce r ,_ t he _ s am e_ ris k_ factor s_ t h at _ pr o du ce d_ t he _f ir st _ c an ce r ,_ un w an te d_ s i de _ eff ec t s_ of_ tr e at in g_ t he _f ir st _ c an ce r_ ( pa r t ic ul ar l y _ ra di ation _ t he ra p y ),_ and_ bet te r_ co m pl i an ce _ w it h _ sc re en ing .
Pre di ct in g_ s ho r t -_ or _ lo n g - te r m _ su r vi va l _ de p en ds _ on _ man y _f act or s. _ T he _ m o st _ im p or t an t_ ar e_ t he _ c an ce r_ typ e_ and_ t he _ pa t ie n t ' s_ ag e_ and_ ov er all _ he al t h ._ T ho se _ w ho _ ar e_ f ra il _ w it h _ ot he r_ he al t h _ pr o bl em s_ h a ve_ lo we r_ su r vi va l _ ra te s_ t h an_ ot he r w is e_ he al t h y _ p e op le ._ C en te n ar i an s_ ar e_ un l i k el y _ to _ su r vi ve_ f or _f iv e_ y e ar s_ e v en_ if _ tr e at me n t_ is _ su c ce ss f ul ._ P e op le _ w ho _ re p or t_ a_ h ig he r_ qu al it y _of_ l if e_ te n d_ to _ su r vi ve_ lo n ge r ._ P e op le _ w it h _ lo we r_ qu al it y _of_ l if e_ m a y _ be _ af f ec te d_ b y _ de pr e ss ion _ and_ ot he r_ co m pl ic ation s_ and / or _ di se as e_ pr og re ss ion _ t h at _ b ot h _ im pa ir s_ qu al it y _ and_ qu an t it y _of_ l if e ._ A d di t ion all y ,_ pa t ie n t s_ w it h _ wor se _ pr og no se s_ m a y _ be _ de pr e ss e d_ or _ re p or t_ p oo re r_ qu al it y _of_ l if e_ be c a u se _ t he y _ p er ce iv e_ t h at _ t he ir _ co n di t ion _ is _ l i k el y _ to _ be _f at al .
P e op le _ w it h _ c an ce r_ h a ve_ an_ in c re as e d_ ris k_ of_ bl oo d_ c lo t s_ in_ t he ir _ v ei n s_ w h ic h _ c an_ be _ l if e - t h re at en ing ._ T he _ u se _of_ bl oo d_ t h in ne r s_ su ch_ as _ he pa r in_ de c re as e_ t he _ ris k_ of_ bl oo d_ c lo t s_ b ut _ h a ve_ no t_ be en_ s ho w n_ to _ in c re as e_ su r vi va l _ in_ p e op le _ w it h _ c an ce r ._ P e op le _ w ho _ t ak e_ bl oo d_ t h in ne r s_ al s o _ h a ve_ an_ in c re as e d_ ris k_ of_ bl ee di n g .
Al t hou g h _ ex tr em el y _ ra re ,_ som e_ f orm s_ of_ c an ce r ,_ e v en _f ro m _ an_ a d va n ce d_ st ag e,_ c an_ he al_ sp ont an e o u sl y ._ T h is _ p he no me no n_ is _ k no w n_ as _ sp ont an e o u s_ re mi ss ion .

E p i de mi olog y
E st im at e s_ ar e_ t h at _ in_ 201 8 ,_ 1 8 . 1 _ mi l l ion _ ne w _ c as e s_ of_ c an ce r_ and_ 9 . 6 _ mi l l ion _ de at h s_ o c cur _ g lo b all y ._ A b o ut _ 20 % _of_ mal e s_ and_ 1 7 % _of_ f em al e s_ w ill _ ge t_ c an ce r_ at _ som e_ p o in t_ in_ t im e_ w h il e_ 1 3 % _of_ mal e s_ and_ 9 % _of_ f em al e s_ w ill _ di e_ f ro m _ it .
In _ 20 0 8 ,_ ap pr o x im at el y _ 1 2 . 7 _ mi l l ion _ c an ce r s_ we re _ di ag no se d_ ( ex c l u di n g_ no n - me l an om a_ s kin _ c an ce r s_ and_ ot he r_ no n - in va s iv e_ c an ce r s )_ and_ in_ 201 0_ ne ar l y _ 7 . 9 8 _ mi l l ion _ p e op le _ di e d. _ C an ce r s_ a c co un t_ f or _ al m o st _ on e_ in_ s i x _ de at h s. _ T he _ c an ce r s_ c a u s in g_ t he _ m o st _ de at h s ,_ as _of_ 20 20 _ ar e_ l un g_ c an ce r_ ( 1 . 8 _ mi l l ion ),_ co lo re ct al_ c an ce r_ ( 9 1 6 , 0 0 0 ),_ l iv er_ c an ce r_ ( 8 3 0 , 0 0 0 ),_ st oma ch_ c an ce r_ ( 7 6 9 , 0 0 0 )_ and_ br e as t_ c an ce r_ ( 6 8 5 , 0 0 0 ). _ T h is _ mak e s_ in va s iv e_ c an ce r_ t he _ le a di n g_ c a u se _of_ de at h _ in_ t he _ de v el op e d_ wor l d_ and_ t he _ se co n d_ le a di n g_ in_ t he _ de v el op in g_ wor l d. _ O ver _ h al f_ of_ t he se _ c as e s_ o c cur _ in_ t he _ de v el op in g_ wor l d.
D e at h s_ f ro m _ c an ce r_ we re _ 5 . 8 _ mi l l ion _ in_ 1 9 9 0 ._D e at h s_ h a ve_ be en_ in c re as in g_ pr im ar il y _ du e_ to _ lo n ge r_ l if e sp an s_ and_ l if e st yl e_ ch an ge s_ in_ t he _ de v el op in g_ wor l d. _ T he _ m o st _ s ign if ic an t_ ris k_ factor _f or _ de v el op in g_ c an ce r_ is _ ag e ._ Al t hou g h _ it _ is _ p o ss i bl e_ f or _ c an ce r_ to _ str i k e_ at _ an y _ ag e,_ m o st _ pa t ie n t s_ w it h _ in va s iv e_ c an ce r_ ar e_ ov er_ 6 5 ._ A c co r di n g_ to _ c an ce r_ re se ar ch er_ R o be r t_ A ._ W ei n be rg ,_ " I f_ we _ l iv e d_ lo n g_ en o u g h ,_ s oo ne r_ or _ l at er_ we _ all _ w o ul d_ ge t_ c an ce r . "_ S om e_ of_ t he _ as s o ci ation _ bet we en_ ag in g_ and_ c an ce r_ is _ at tr i b ut e d_ to _ im mu no se ne sc en ce ,_ er ro r s_ a c c um ul at e d_ in_ DNA _ ov er_ a_ l if et im e_ and_ ag e - re l at e d_ ch an ge s_ in_ t he _ en do c r in e_s y st em ._ A g ing ' s_ eff ect_ on _ c an ce r_ is _ co m pl ic at e d_ b y _f act or s_ su ch_ as _ DNA _ d am ag e_ and_ in f l am mat ion _ pr om ot in g_ it _ and_ factor s_ su ch_ as _ va sc ul ar _ ag in g_ and_ en do c r in e_ ch an ge s_ in h i b it in g_ it .
S om e_ sl o w - gro w in g_ c an ce r s_ ar e_ pa r t ic ul ar l y _ co m m on ,_ b ut _ o f te n_ ar e_ no t_ f at al ._ A ut op s y _ st u di e s_ in_ Europ e_ and_ A s i a_ s ho we d_ t h at _ u p _ to _ 3 6 % _of_ p e op le _ h a ve_ un di ag no se d_ and_ ap pa re n t l y _ h arm le ss _ t h y ro i d_ c an ce r_ at _ t he _ t im e_ of_ t he ir _ de at h s_ and_ t h at _ 8 0 % _of_ me n_ de v el op_ pr o st at e_ c an ce r_ b y _ ag e_ 8 0 ._ A s_ t he se _ c an ce r s_ do _ no t_ c a u se _ t he _ pa t ie n t ' s_ de at h ,_ i de n t if y in g_ t he m _ w o ul d_ h a ve_ re pr e se n te d_ ov er di ag no s is _ ra t he r_ t h an_ u se f ul _ medic al_ car e .
T he _ t h re e_ m o st _ co m m on _ ch il d ho o d_ c an ce r s_ ar e_ leukem i a_ ( 3 4 % ),_ br a in_ tu m or s_( 2 3 % )_ and_ lym p ho m as _( 1 2 % ). _ In _ t he _ U n it e d_ S t at e s_ c an ce r_ af f ec t s_ ab o ut _ 1 _ in_ 2 8 5 _ ch il d re n ._ R at e s_ of_ ch il d ho o d_ c an ce r_ in c re as e d_ b y _ 0 . 6 % _ p er_ y e ar _ bet we en_ 1 9 7 5 _ and_ 20 0 2 _ in_ t he _ U n it e d_ S t at e s_ and_ b y _ 1 . 1 % _ p er_ y e ar _ bet we en_ 1 9 7 8 _ and_ 1 9 9 7 _ in_ Europe ._D e at h _f ro m _ ch il d ho o d_ c an ce r_ de c re as e d_ b y _ h al f_ bet we en_ 1 9 7 5 _ and_ 201 0_ in_ t he _ U n it e d_ S t at e s.

H is to r y
C an ce r_ h as _ ex is te d_ f or _ all _of_ hu man _ h is to r y ._ T he _ e ar l ie st _ w r it te n_ re co r d_ reg ar di n g_ c an ce r_ is _f ro m _ c .   1 6 0 0_ B C _ in_ t he _ E g yp t i an_ E d w in_ S mi t h _ P ap y ru s_ and_ de sc r i be s_ br e as t_ c an ce r ._ H i p p o c ra te s_( c .   4 6 0_ B C _ – _ c .   3 7 0_ B C )_ de sc r i be d_ se ver al_ kin ds _of_ c an ce r ,_ re f er r in g_ to _ t he m _ w it h _ t he _ G reek _ wor d_ κ α ρ κ ί ν ο ς _ k ar kin o s_( c ra b _ or _ c ra y f is h ). _ T h is _ nam e_ co me s_ f ro m _ t he _ ap p e ar an ce _of_ t he _ c ut _ su rf a ce _of_ a_ s ol i d_ malign an t_ tu m or ,_ w it h _ " t he _ v ei n s_ st re t ch e d_ on _ all _ s i de s_ as _ t he _ an im al_ t he _ c ra b _ h as _ it s_ f ee t,_ w he n ce _ it _ de r iv e s_ it s_ nam e " ._ G al en_ st at e d_ t h at _ " c an ce r_ of_ t he _ br e as t_ is _ s o _ c al le d_ be c a u se _of_ t he _f an ci e d_ re se m bl an ce _ to _ a_ c ra b _ g iv en_ b y _ t he _ l at er al_ pr ol ong ation s_ of_ t he _ tu m or _ and_ t he _ a d j a ce n t_ di st en de d_ v ei n s " ._ C el su s_( c .   2 5 _ B C _ – _ 5 0_ A D )_ tran sl at e d_ k ar kin o s_ in to _ Lat in_ as _ c an ce r ,_ al s o _ me an in g_ c ra b _ and_ re co m me n de d_ su rg er y _ as _ tr e at me n t._ G al en _( 2 n d_ ce n tu r y _ A D )_ di s ag ree d_ w it h _ t he _ u se _of_ su rg er y _ and_ re co m me n de d_ p ur g at iv e s_ in st e a d. _ T he se _ re co m me n d ation s_ l ar ge l y _ st oo d_ f or _ 1 0 0 0_ y e ar s.
In _ t he _ 1 5 t h ,_ 1 6 t h _ and_ 1 7 t h _ ce n tu r ies ,_ it _ be c am e_ a c ce pt ab le _f or _ do ct or s_ to _ di ss ect_ b o di e s_ to _ di sc ov er_ t he _ c a u se _of_ de at h ._ T he _ G er man _ pr o f e ss or _ W il he l m _ F ab r y _ be l iev e d_ t h at _ br e as t_ c an ce r_ w as _ c a u se d_ b y _ a_ mi l k_ c lo t_ in_ a_ m am m ar y _ du ct ._ T he _ D ut ch_ pr o f e ss or _ F ra n co is _ de _ l a_ B oe _ S yl vi u s ,_ a_ f ol lo we r_ of_ D e sc ar te s ,_ be l iev e d_ t h at _ all _ di se as e_ w as _ t he _ o ut co me _of_ chemic al_ pr o ce ss e s_ and_ t h at _ a ci di c _ lym p h _f l ui d_ w as _ t he _ c a u se _of_ c an ce r ._ H is _ co n te m p or ar y _ N ic ol a e s_ T ul p _ be l iev e d_ t h at _ c an ce r_ w as _ a_ p o is on _ t h at _ sl o w l y _ sp re a ds _ and_ co n c l u de d_ t h at _ it _ w as _ co n t ag i o u s.
T he _ p h y s ic i an_ J o h n_ H ill _ de sc r i be d_ to b a c co _ sn if f in g_ as _ t he _ c a u se _of_ no se _ c an ce r_ in_ 1 7 6 1 ._ T h is _ w as _f ol lo we d_ b y _ t he _ re p or t_ in_ 1 7 7 5 _ b y _ B r it is h _ su rg e on _ P er ci va l l _ P ot t_ t h at _ ch im ne y _ s we ep s '_ car ci no m a ,_ a_ c an ce r_ of_ t he _ sc ro tu m ,_ w as _ a_ co m m on _ di se as e_ am on g_ ch im ne y _ s we ep s. _ W it h _ t he _ w i de sp re a d_ u se _of_ t he _ mi c ro sc op e_ in_ t he _ 1 8 t h _ ce n tu r y ,_ it _ w as _ di sc ov er e d_ t h at _ t he _ ' c an ce r_ p o is on '_ sp re a d_ f ro m _ t he _ pr im ar y _ tu m or _ t h ro u g h _ t he _ lym p h _ no de s_ to _ ot he r_ s it e s_( " met as t as is " ). _ T h is _ vi e w _of_ t he _ di se as e_ w as _f ir st _f or mu l at e d_ b y _ t he _ E n g l is h _ su rg e on _ C am p be l l _ De_ M org an_ bet we en_ 1 8 7 1 _ and_ 1 8 7 4 .

S o ci et y _ and_ c ul tu re
Al t hou g h _ man y _ di se as e s_( su ch_ as _ he ar t_ f a il ur e )_ m a y _ h a ve_ a_ wor se _ pr og no s is _ t h an_ m o st _ c as e s_ of_ c an ce r ,_ c an ce r_ is _ t he _ su b j ect_ of_ w i de sp re a d_ f e ar _ and_ t ab oo s. _ T he _ e u p he mi s m _of_ " a_ lo n g_ ill ne ss "_ to _ de sc r i be _ c an ce r s_ le a di n g_ to _ de at h _ is _ st ill _ co m m on l y _ u se d_ in_ o b itu ar ies ,_ ra t he r_ t h an_ nam in g_ t he _ di se as e_ ex pl ic it l y ,_ re f le ct in g_ an_ ap pa re n t_ st ig m a ._ C an ce r_ is _ al s o _ e u p he mi se d_ as _ " t he _ C - wor d " ;_ M a c mi l l an_ C an ce r_ S u p p or t_ u se s_ t he _ te r m _ to _ tr y _ to _ le ssen_ t he _f e ar _ ar o un d_ t he _ di se as e ._ In _ N ig er i a ,_ on e_ lo c al_ nam e_ f or _ c an ce r_ tran sl at e s_ in to _ E n g l is h _ as _ " t he _ di se as e_ t h at _ c an no t_ be _ cur e d " ._ T h is _ de ep _ be l ief_ t h at _ c an ce r_ is _ ne ce ss ar il y _ a_ di ff ic ul t_ and_ u su all y _ de a d l y _ di se as e_ is _ re f le ct e d_ in_ t he _ s y st em s_ ch o se n_ b y _ s o ci et y _ to _ co m p il e_ c an ce r_ st at is t ic s :_ t he _ m o st _ co m m on _f orm _of_ c an ce r — no n - me l an om a_ s kin _ c an ce r s ,_ a c co un t in g_ f or _ ab o ut _ on e - t h ir d_ of_ c an ce r_ c as e s_ wor l d w i de ,_ b ut _ ver y _f e w _ de at h s — ar e_ ex c l u de d_ f ro m _ c an ce r_ st at is t ic s_ specif ic all y _ be c a u se _ t he y _ ar e_ e as il y _ tr e at e d_ and_ al m o st _ al w a y s_ cur e d,_ o f te n_ in_ a_ s ing le ,_ s ho r t,_ o ut pa t ie n t_ pr o ce du re .
W e st er n_ co n ce pt ion s_ of_ pa t ie n t s '_ r ig h t s_ f or _ p e op le _ w it h _ c an ce r_ in c l u de _ a_ du t y _ to _f ul l y _ di sc lo se _ t he _ medic al_ s itu ation _ to _ t he _ p er s on ,_ and_ t he _ r ig h t_ to _ en g ag e_ in_ s h ar e d_ de ci s ion - mak in g_ in_ a_ w a y _ t h at _ resp ec t s_ t he _ p er s on ' s_ o w n_ va l u e s. _ In _ ot he r_ c ul tu re s ,_ ot he r_ r ig h t s_ and_ va l u e s_ ar e_ pr e f er re d. _ F or _ ex am pl e,_ m o st _ A f r ic an_ c ul tu re s_ va l u e_ w ho le _f am il ie s_ ra t he r_ t h an_ in di vi du al is m ._ In _ pa r t s_ of_ A f r ic a ,_ a_ di ag no s is _ is _ co m m on l y _ m a de _ s o _ l at e_ t h at _ cur e_ is _ no t_ p o ss i bl e,_ and_ tr e at me n t,_ if _ a va il ab le _ at _ all ,_ w o ul d_ qu ic kl y _ b ank ru pt _ t he _f am il y ._ A s_ a_ re su l t_ of_ t he se _f act or s ,_ A f r ic an_ he al t h car e_ pr ov i de r s_ te n d_ to _ le t_ f am il y _ me m be r s_ de ci de _ w he t he r ,_ w he n_ and_ ho w _ to _ di sc lo se _ t he _ di ag no s is,_ and_ t he y _ te n d_ to _ do _ s o _ sl o w l y _ and_ ci r c ui to u sl y ,_ as _ t he _ p er s on _ s ho w s_ in te re st _ and_ an_ ab il it y _ to _ co p e_ w it h _ t he _ g r im _ ne w s. _ P e op le _f ro m _ A s i an_ and_ S o ut h _ A me r ic an_ co un tr ie s_ al s o _ te n d_ to _ pr e f er_ a_ sl o we r ,_ le ss _ c an di d_ ap pr o a ch_ to _ di sc lo su re _ t h an_ is _ i de al i z e d_ in_ t he _ U n it e d_ S t at e s_ and_ W e st er n_ Europ e,_ and_ t he y _ be l ieve_ t h at _ som et im e s_ it _ w o ul d_ be _ pr e f er ab le _ no t_ to _ be _ to l d_ ab o ut _ a_ c an ce r_ di ag no s is ._ In _ ge ne ra l ,_ di sc lo su re _of_ t he _ di ag no s is _ is _ m or e_ co m m on _ t h an_ it _ w as _ in_ t he _ 20 t h _ ce n tu r y ,_ b ut _f ul l _ di sc lo su re _of_ t he _ pr og no s is _ is _ no t_ o ff er e d_ to _ man y _ pa t ie n t s_ ar o un d_ t he _ wor l d.
In _ t he _ U n it e d_ S t at e s_ and_ som e_ ot he r_ c ul tu re s ,_ c an ce r_ is _ reg ar de d_ as _ a_ di se as e_ t h at _ mu st _ be _ " f o u g h t "_ to _ end_ t he _ " ci vi l _ in su r re ct ion " ;_ a_ w ar _ on _ c an ce r_ w as _ de c l ar e d_ in_ t he _ U S ._ M il it ar y _ met ap ho r s_ ar e_ pa r t ic ul ar l y _ co m m on _ in_ de sc r i pt ion s_ of_ c an ce r ' s_ hu man _ eff ec t s ,_ and_ t he y _ em p h as i ze_ b ot h _ t he _ st at e_ of_ t he _ pa t ie n t ' s_ he al t h _ and_ t he _ ne e d_ to _ t ak e_ im medi at e,_ de ci s iv e_ act ion s_ h im se l f_ ra t he r_ t h an_ to _ de l a y ,_ to _ ig no re _ or _ to _ re l y _ ent ir el y _ on _ ot he r s. _ T he _ mi l it ar y _ met ap ho r s_ al s o _ he l p _ ra t ion al i ze_ ra di c al ,_ de st ru ct iv e_ tr e at me n t s.
In _ t he _ 1 9 7 0 s ,_ a_ re l at iv el y _ p op ul ar _ al te r n at iv e_ c an ce r_ tr e at me n t_ in_ t he _ U S _ w as _ a_ spec ial i z e d_ f orm _of_ t al k_ t he ra p y ,_ b as e d_ on _ t he _ i de a_ t h at _ c an ce r_ w as _ c a u se d_ b y _ a_ b a d_ at t itu de ._ P e op le _ w it h _ a_ " c an ce r_ p er s on al it y " — de pr e ss e d,_ re pr e ss e d,_ se l f - lo at h in g_ and_ af ra i d_ to _ ex pr e ss _ t he ir _ em ot ion s — we re _ be l iev e d_ to _ h a ve_ man if e st e d_ c an ce r_ t h ro u g h _ su b co n sc i o u s_ de s ir e ._ S om e_ p s y ch ot he ra p is t s_ c l a im e d_ t h at _ tr e at me n t_ to _ ch an ge _ t he _ pa t ie n t ' s_ o ut lo ok_ on _ l if e_ w o ul d_ cur e_ t he _ c an ce r ._ A m on g_ ot he r_ eff ec t s ,_ t h is _ be l ief_ al lo we d_ s o ci et y _ to _ bl am e_ t he _ vi ct im _f or _ h a vi n g_ c a u se d_ t he _ c an ce r_ ( b y _ " w an t ing "_ it )_ or _ h a vi n g_ pr e v en te d_ it s_ cur e_ ( b y _ no t_ be co mi n g_ a_ su ff ic ie n t l y _ h ap p y ,_ f e ar le ss _ and_ lo vi n g_ p er s on ). _ I t_ al s o _ in c re as e d_ pa t ie n t s '_ an x iet y ,_ as _ t he y _ in co r re ct l y _ be l iev e d_ t h at _ n at ur al_ em ot ion s_ of_ s a d ne ss ,_ an ge r_ or _f e ar _ s ho r te n_ t he ir _ l iv e s. _ T he _ i de a_ w as _ r i di c ul e d_ b y _ S u s an_ S ont ag ,_ w ho _ p u bl is he d_ I l l ne ss _ as _ M et ap ho r_ w h il e_ re co ver in g_ f ro m _ tr e at me n t_ f or _ br e as t_ c an ce r_ in_ 1 9 7 8 ._ Al t hou g h _ t he _ or ig in al_ i de a_ is _ no w _ ge ne ra l l y _ reg ar de d_ as _ no n se n se ,_ t he _ i de a_ pa r t l y _ p er s is t s_ in_ a_ re du ce d_ f orm _ w it h _ a_ w i de sp re a d,_ b ut _ in co r re ct ,_ be l ief_ t h at _ de l i be ra te l y _ c ul t iv at in g_ a_ h ab it _of_ p o s it iv e_ t h in kin g_ w ill _ in c re as e_ su r vi va l ._ T h is _ no t ion _ is _ pa r t ic ul ar l y _ st ro n g_ in_ br e as t_ c an ce r_ c ul tu re .
O ne _ i de a_ ab o ut _ w h y _ p e op le _ w it h _ c an ce r_ ar e_ bl am e d_ or _ st ig mat i z e d,_ c al le d_ t he _ j u st - wor l d_ f all a cy ,_ is _ t h at _ bl am in g_ c an ce r_ on _ t he _ pa t ie n t ' s_ act ion s_ or _ at t itu de s_ al lo w s_ t he _ bl am ers_ to _ reg a in_ a_ se n se _of_ co n tr ol ._ T h is _ is _ b as e d_ u p on _ t he _ bl am er s '_ be l ief_ t h at _ t he _ wor l d_ is _f un d amen t all y _ j u st _ and_ s o _ an y _ d an ge ro u s_ ill ne ss ,_ l i k e_ c an ce r ,_ mu st _ be _ a_ typ e_ of_ p un is h me n t_ f or _ b a d_ ch o ic e s ,_ be c a u se _ in_ a_ j u st _ wor l d,_ b a d_ t h ing s_ w o ul d_ no t_ h ap p en_ to _ g oo d_ p e op le .

E co no mi c _ eff ec t
T he _ to t al_ he al t h _ car e_ ex p en di tu re _ on _ c an ce r_ in_ t he _ U S _ w as _ e st im at e d_ to _ be _ $ 8 0 . 2 _ b ill ion _ in_ 201 5 ._E v en_ t hou g h _ c an ce r - re l at e d_ he al t h _ car e_ ex p en di tu re _ h a ve_ in c re as e d_ in_ ab s ol ut e_ te r m s_ du r in g_ re ce n t_ de c a de s ,_ t he _ s h ar e_ of_ he al t h _ ex p en di tu re _ de v ot e d_ to _ c an ce r_ tr e at me n t_ h as _ re m a in e d_ c lo se _ to _ 5 % _ bet we en_ t he _ 1 9 6 0 s_ and_ 20 0 4 ._ A _ s im il ar _ pa t te r n_ h as _ be en_ o b se r v e d_ in_ Europ e_ w he re _ ab o ut _ 6 % _of_ all _ he al t h _ car e_ ex p en di tu re _ ar e_ sp ent_ on _ c an ce r_ tr e at me n t._ In _ a d di t ion _ to _ he al t h _ car e_ ex p en di tu re _ and_ f in an ci al_ to x ic it y ,_ c an ce r_ c a u se s_ in di re ct _ co st s_ in_ t he _f orm _of_ pr o du ct iv it y _ lo ss e s_ du e_ to _ s ic k_ d a y s ,_ p er man ent_ in c ap a ci t y _ and_ di s ab il it y _ as _ we l l _ as _ pr em at ur e_ de at h _ du r in g_ wor kin g_ ag e ._ C an ce r_ c a u se s_ al s o _ co st s_ f or _ in f orm al_ car e ._ In di re ct _ co st s_ and_ in f orm al_ car e_ co st s_ ar e_ typ ic all y _ e st im at e d_ to _ ex ce e d_ or _ e qu al_ t he _ he al t h _ car e_ co st s_ of_ c an ce r .

E ff ect_ on _ di v or ce
A _ st u d y _f o un d_ w om en_ we re _ ar o un d_ s i x _ t im e s_ m or e_ l i k el y _ to _ be _ di v or ce d_ s oo n_ af te r_ a_ di ag no s is _of_ c an ce r_ co m pa re d_ to _ me n ._ R at e_ of_ se pa ra t ion _f or _ c an ce r - su r vi v or s_ s ho we d_ co r re l ation s_ w it h _ ra ce ,_ ag e,_ in co me ,_ and_ co m or b i di t ie s_ in_ a_ st u d y ._ A _ re vi e w _f o un d_ a_ som e w h at _ de c re as e d_ di v or ce _ ra te _f or _ m o st _ c an ce r_ typ e s ,_ and_ no te d_ st u d y _ he te ro ge ne it y _ and_ met ho do lo g ic al_ we ak ne ss e s_ f or _ man y _ st u di e s_ on _ t he _ eff ec t s_ of_ c an ce r_ on _ di v or ce .

R e se ar ch
B ec a u se _ c an ce r_ is _ a_ c l as s_ of_ di se as e s ,_ it _ is _ un l i k el y _ t h at _ t he re _ w ill _ e ver _ be _ a_ s ing le _ " cur e_ f or _ c an ce r "_ an y _ m or e_ t h an_ t he re _ w ill _ be _ a_ s ing le _ tr e at me n t_ f or _ all _ in f ec t i o u s_ di se as e s. _ An g i og en e s is _ in h i b it or s_ we re _ on ce _ in co r re ct l y _ t hou g h t_ to _ h a ve_ p ot ent ial _ as _ a_ " s il ver _ b ul le t "_ tr e at me n t_ ap pl ic ab le _ to _ man y _ typ e s_ of_ c an ce r ._ An g i og en e s is _ in h i b it or s_ and_ ot he r_ c an ce r_ t he ra p e ut ic s_ ar e_ u se d_ in_ co m b in ation _ to _ re du ce _ c an ce r_ m or b i di t y _ and_ m or t al it y .
E x p er im ent al_ c an ce r_ tr e at me n t s_ ar e_ st u di e d_ in_ c l in ic al_ tr ial s_ to _ co m pa re _ t he _ pr op o se d_ tr e at me n t_ to _ t he _ best _ ex is t in g_ tr e at me n t._ T re at me n t s_ t h at _ su c ce e de d_ in_ on e_ c an ce r_ typ e_ c an_ be _ te st e d_ ag a in st _ ot he r_ typ e s. _ D i ag no st ic _ te st s_ ar e_ un de r_ de v el op me n t_ to _ bet te r_ t ar ge t_ t he _ r ig h t_ t he ra p ie s_ to _ t he _ r ig h t_ pa t ie n t s ,_ b as e d_ on _ t he ir _ in di vi du al_ b i olog y .
C an ce r_ re se ar ch _f o c u se s_ on _ t he _f ol lo w in g_ is su e s :

A ge n t s_( e . g ._ viru se s )_ and_ e vent s_( e . g ._ mut ation s )_ t h at _ c a u se _ or _f a ci l it at e_ ge ne t ic _ ch an ge s_ in_ ce l l s_ de st in e d_ to _ be co me _ c an ce r .
T he _ pr ec is e_ n at ur e_ of_ t he _ ge ne t ic _ d am ag e_ and_ t he _ ge ne s_ t h at _ ar e_ af f ec te d_ b y _ it .
T he _ co n se qu en ce s_ of_ t ho se _ ge ne t ic _ ch an ge s_ on _ t he _ b i olog y _of_ t he _ ce l l ,_ b ot h _ in_ ge ne ra t in g_ t he _ de f in in g_ pr oper t ie s_ of_ a_ c an ce r_ ce l l _ and_ in _f a ci l it at in g_ a d di t ion al_ ge ne t ic _ e vent s_ t h at _ le a d_ to _f ur t he r_ pr og re ss ion _of_ t he _ c an ce r .
T he _ im pr ov e d_ un de r st an di n g_ of_ m ol ec ul ar _ b i olog y _ and_ ce l l ul ar _ b i olog y _ du e_ to _ c an ce r_ re se ar ch_ h as _ le d_ to _ ne w _ tr e at me n t s_ f or _ c an ce r_ s in ce _ U S _ Pre s i de n t_ R ic h ar d_ N i x on _ de c l ar e d_ t he _ " w ar _ on _ c an ce r "_ in_ 1 9 7 1 ._ S in ce _ t he n ,_ t he _ co un tr y _ h as _ sp ent_ ov er_ $ 20 0_ b ill ion _ on _ c an ce r_ re se ar ch ,_ in c l u di n g_ re s o ur ce s_ f ro m _ p u bl ic _ and_ pr iv at e_ se ct or s. _ T he _ c an ce r_ de at h _ ra te _( a d j u st in g_ f or _ s i ze_ and_ ag e_ of_ t he _ p op ul ation )_ de c l in e d_ b y _f iv e_ p er ce n t_ bet we en_ 1 9 5 0_ and_ 20 0 5 .
C om p et it ion _f or _f in an ci al_ re s o ur ce s_ ap p e ar s_ to _ h a ve_ sup pr e ss e d_ t he _ c re at iv it y ,_ co oper ation ,_ ris k - t ak in g_ and_ or ig in al_ t h in kin g_ re qu ir e d_ to _ mak e_ f un d amen t al_ di sc ov er ies ,_ un du l y _f a v or in g_ lo w - ris k_ re se ar ch_ in to _ s mal l _ in c re me n t al_ a d va n ce me n t s_ ov er_ ris k ie r ,_ m or e_ in no va t iv e_ re se ar ch ._ O t he r_ co n se qu en ce s_ of_ co m p et it ion _ ap p e ar _ to _ be _ man y _ st u di e s_ w it h _ dra mat ic _ c l a im s_ w ho se _ re su l t s_ c an no t_ be _ re pl ic at e d_ and_ p erv er se _ in ce n t iv e s_ t h at _ en co ur ag e_ g ra n te e_ in st it ut ion s_ to _ gro w _ w it ho ut _ mak in g_ su ff ic ie n t_ inv e st me n t s_ in_ t he ir _ o w n_ f a c ul t y _ and_ f a ci l it ie s.
V ir ot he ra p y ,_ w h ic h _ u se s_ co n ver t_ viru se s ,_ is _ be in g_ st u di e d.
In _ t he _ w ak e_ of_ t he _ C O V I D - 1 9 _ pa n de mi c ,_ t he re _ h as _ be en_ a_ wor r y _ t h at _ c an ce r_ re se ar ch_ and_ tr e at me n t_ ar e_ sl o w in g_ do w n .

Pre g n an cy
C an ce r_ af f ec t s_ ap pr o x im at el y _ 1 _ in_ 1 , 0 0 0_ pr eg n an t_ w om en._ T he _ m o st _ co m m on _ c an ce r s_ f o un d_ du r in g_ pr eg n an cy _ ar e_ t he _ s am e_ as _ t he _ m o st _ co m m on _ c an ce r s_ f o un d_ in_ no n - pr eg n an t_ w om en_ du r in g_ ch il d be ar in g_ ag e s :_ br e as t_ c an ce r ,_ ce r vi c al_ c an ce r ,_ leukem i a ,_ lym p ho m a ,_ me l an oma ,_ ov ar i an_ c an ce r_ and_ co lo re ct al_ c an ce r .
D i ag no s in g_ a_ ne w _ c an ce r_ in_ a_ pr eg n an t_ w om an_ is _ di ff ic ul t,_ in_ pa r t_ be c a u se _ an y _ s ymptom s_ ar e_ co m m on l y _ as su me d_ to _ be _ a_ no r mal _ di sc om f or t_ as s o ci at e d_ w it h _ pr eg n an cy ._ A s_ a_ re su l t,_ c an ce r_ is _ typ ic all y _ di sc ov er e d_ at _ a_ som e w h at _ l at er_ st ag e_ t h an_ a ver ag e ._ S om e_ im ag in g_ pr o ce du re s ,_ su ch_ as _ M R I s_( m ag ne t ic _ re s on an ce _ im ag ing ),_ C T _ scan s ,_ ul tr as o un ds _ and_ m am mog ra m s_ w it h _f et al_ s h ie l di n g_ ar e_ co n s i de re d_ s af e_ du r in g_ pr eg n an cy ;_ som e_ ot he r s ,_ su ch_ as _ P E T _ scan s ,_ ar e_ no t .
T re at me n t_ is _ ge ne ra l l y _ t he _ s am e_ as _f or _ no n - pr eg n an t_ w om en._ H o we ver ,_ ra di ation _ and_ ra di o act iv e_ d ru g s_ ar e_ no r mal l y _ a v o i de d_ du r in g_ pr eg n an cy ,_ e spec ial l y _ if _ t he _f et al_ do se _ mi g h t_ ex ce e d_ 1 0 0_ c G y ._ In _ som e_ c as e s ,_ som e_ or _ all _ tr e at me n t s_ ar e_ p o st p on e d_ un t il _ af te r_ b ir t h _ if _ t he _ c an ce r_ is _ di ag no se d_ l at e_ in_ t he _ pr eg n an cy ._E ar l y _ de l iv er ie s_ ar e_ o f te n_ u se d_ to _ a d va n ce _ t he _ st ar t_ of_ tr e at me n t._ S ur ge r y _ is _ ge ne ra l l y _ s af e,_ b ut _ p el vi c _ su rg er ie s_ du r in g_ t he _f ir st _ tr im e st er_ m a y _ c a u se _ mi sc ar r i ag e ._ S om e_ tr e at me n t s ,_ e spec ial l y _ ce r t a in_ chem ot he ra p y _ d ru g s_ g iv en_ du r in g_ t he _f ir st _ tr im e st er ,_ in c re as e_ t he _ ris k_ of_ b ir t h _ de f ec t s_ and_ pr eg n an cy _ lo ss _( sp ont an e o u s_ ab or t ion s_ and_ st ill b ir t h s ).
E le ct iv e_ ab or t ion s_ ar e_ no t_ re qu ir e d_ and ,_ f or _ t he _ m o st _ co m m on _f orm s_ and_ st ag e s_ of_ c an ce r ,_ do _ no t_ im pr ov e_ t he _ m ot he r ' s_ su r vi va l ._ In _ a_ f e w _ in st an ce s ,_ su ch_ as _ a d va n ce d_ ut er in e_ c an ce r ,_ t he _ pr eg n an cy _ c an no t_ be _ co n t in u e d_ and_ in_ ot he r s ,_ t he _ pa t ie n t_ m a y _ end_ t he _ pr eg n an cy _ s o _ t h at _ s he _ c an_ be g in_ ag g re ss iv e_ chem ot he ra p y .
S om e_ tr e at me n t s_ c an_ in te rf er e_ w it h _ t he _ m ot he r ' s_ ab il it y _ to _ g iv e_ b ir t h _ va g in all y _ or _ to _ br e as t f ee d. _ C er vi c al_ c an ce r_ m a y _ re qu ir e_ b ir t h _ b y _ C a e s ar e an_ se ct ion ._ R a di ation _ to _ t he _ br e as t_ re du ce s_ t he _ ab il it y _of_ t h at _ br e as t_ to _ pr o du ce _ mi l k_ and_ in c re as e s_ t he _ ris k_ of_ m as t it is ._ Al s o ,_ w he n_ chem ot he ra p y _ is _ g iv en_ af te r_ b ir t h ,_ man y _of_ t he _ d ru g s_ ap p e ar _ in_ br e as t_ mi l k ,_ w h ic h _ co ul d_ h arm _ t he _ b ab y .

O t he r_ an im al s
V et er in ar y _ onco lo g y ,_ co n ce n tr at in g_ m a in l y _ on _ c at s_ and_ do g s ,_ is _ a_ gro w in g_ spec ial t y _ in_ we al t h y _ co un tr ie s_ and_ t he _ m a j or _f orm s_ of_ hu man _ tr e at me n t_ su ch_ as _ su rg er y _ and_ ra di ot he ra p y _ m a y _ be _ o ff er e d. _ T he _ m o st _ co m m on _ typ e s_ of_ c an ce r_ di ff er ,_ b ut _ t he _ c an ce r_ b ur de n_ se em s_ at _ le as t_ as _ h ig h _ in_ p et s_ as _ in_ hu man s. _ An im al s ,_ typ ic all y _ ro de n t s ,_ ar e_ o f te n_ u se d_ in_ c an ce r_ re se ar ch_ and_ st u di e s_ of_ n at ur al_ c an ce r s_ in_ l ar ge r_ an im als_ m a y _ be ne f it _ re se ar ch_ in to _ hu man _ c an ce r .
A c ro ss _ w il d_ an im al s ,_ t he re _ is _ st ill _ l im it e d_ d at a_ on _ c an ce r ._ N on et he le ss ,_ a_ st u d y _ p u bl is he d_ in_ 20 2 2 ,_ ex pl or e d_ c an ce r_ ris k_ in _( no n - do me st ic at e d )_ zo o _ m am mal s ,_ be lo n g in g_ to _ 1 9 1 _ spec ies ,_ 1 1 0 , 1 4 8 _ in di vi du al ,_ de m on st ra te d_ t h at _ c an ce r_ is _ a_ u b i qu it o u s_ di se as e_ of_ m am mal s_ and_ it _ c an_ em er ge _ an y w he re _ al on g_ t he _ m am mal i an_ p h yl og en y ._ T h is _ re se ar ch_ al s o _ h ig h lig h te d_ t h at _ c an ce r_ ris k_ is _ no t_ un if orm l y _ di str i b ut e d_ al on g_ m am mal s. _ F or _ in st an ce ,_ spec ie s_ in_ t he _ or de r_ C ar n iv or a_ ar e_ pa r t ic ul ar l y _ pr on e_ to _ be _ af f ec te d_ b y _ c an ce r_ ( e . g ._ ov er_ 2 5 % _of_ c lo u de d_ le op ar ds ,_ b at - e ar e d_ f o x e s_ and_ re d_ w ol v e s_ di e_ of_ c an ce r ),_ w h il e_ un g ul at e s_( e spec ial l y _ e v en - to e d_ un g ul at e s )_ ap p e ar _ to _f a ce _ co n s is te n t l y _ lo w _ c an ce r_ ris k s.
In _ no n - hu man s ,_ a_ f e w _ typ e s_ of_ tran s mi ss i bl e_ c an ce r_ h a ve_ al s o _ be en_ de sc r i be d,_ w he re in_ t he _ c an ce r_ sp re a ds _ bet we en_ an im als_ b y _ tran s mi ss ion _of_ t he _ tu m or _ ce l l s_ t he m se l v e s. _ T h is _ p he no me no n_ is _ se en_in_ do g s_ w it h _ S t ic k er ' s_ s ar co m a_ ( al s o _ k no w n_ as _ c an in e_ tran s mi ss i bl e_ v en er e al_ tu m or ),_ and_ in_ T as man i an_ de vi l s_ w it h _ de vi l _f a ci al_ tu m o ur _ di se as e_ ( D F T D ).

S ee _ al s o
C an ce r_ sc re en ing
C an ce r_ tr e at me n t
C a u se s_ of_ c an ce r
E p i de mi olog y _of_ c an ce r
O c c u pa t ion al_ c an ce r
O n co lo g y
M et ab ol ic _ t he or y _of_ c an ce r

R e f eren ce s
F ur t he r_ re a di n g
E x te r n al_ l in k s

I A RC _ P u bl ic ation s_( W H O )_ | _ P u bl ic ation s. i ar c . f r
" O n_ te l l in g_ c an ce r_ pa t ie n t s_ to _ h a ve_ a_ p o s it iv e_ at t itu de "_ at _ T he _ A t l an t ic
W H O _f act _ s he et _ on _ c an ce r
N ation al_ F ir e f ig h te r_ R eg is tr y _( N F R )_ f or _ C an ce r ,_ N ation al_ Inst it ut e_ f or _ O c c u pa t ion al_ S af et y _ and_ H e al t h _( N I O S H ),_ U S A
S to p _ car ci no ge n s_ at _ wor k ,_ E U _ O S H A ._ T he _ s it e_s h ar e s_ in f orm ation _ to _ he l p _ pr e v ent_ wor k ers_ f ro m _ be in g_ ex p o se d_ to _ car ci no ge n s_ in_ t he _ wor k pl a ce .
O c c u pa t ion al_ C an ce r ,_ N I O S H .
N I O S H _ P o c k et _ g ui de _ to _ chemic al_ h a z ar ds ,_ A p p en di x _ A -_ N I O S H _ P ot ent ial _ O c c u pa t ion al_ C ar ci no ge n s.
